General Capital Limited logo

General Capital Releases 2024 Annual Report

Annual Report26 June 2024GENFinancials

General Capital Limited
Level 8, General Capital House,

115 Queen Street, Auckland CBD

PO Box 1314, Shortland Street,

Auckland, New Zealand. 1140.

Phone +64 9 304 0145


General Capital Releases 2024 Annual Report

General Capital, the NZX listed financial services Group, has today released its Annual Report for the

year ended 31 March 2024.

A copy of the Annual Report is also available on the Company’s website at:

www.gencap.co.nz/financial-reports.

The Managing Director, Mr. Brent King, said "We are very pleased to present our Annual Report to our

shareholders and to the NZX today. It has been a very positive year for General Capital with another

record financial result for the year ended 31 March 2024. This year, we have achieved significant

milestones and delivered a strong financial performance, with a 25% increase in revenue to $17.17

million and a 17% rise in Net Profit After Tax to $2.63 million. These results reflect our dedicated

efforts and strategic initiatives in a challenging and dynamic market environment.”


This announcement was approved by the Directors of General Capital Limited.


ENDS


For further information contact:


Brent King

Managing Director

General Capital Limited

+64 21 632 660

Brent.King@gencap.co.nz


27 June 2024

---

General Capital Limited
Annual Report

For the year ended 31 March 2024

Contents

Directors’ Profiles 2-3

General Finance Directors and Executive 4

Directors’ Report 5-7

Corporate Governance Statement 8-19

Independent Auditors’ Report 20-23

Consolidated Financial Statements:

Consolidated Statement of Comprehensive Income 24

Consolidated Statement of Financial Position 25

Consolidated Statement of Changes in Equity 26

Consolidated Statement of Cash Flows 27

Notes to the Consolidated Financial Statements 28-55

Shareholder and Statutory Information 56-60

Corporate Directory 61

1

Directors’ Profiles
REWI HAMID BUGO B.Sc., M.Com.

Non-executive Chairman

Rewi Hamid Bugo has been a Non-executive Director of General Capital

Limited since 13 June 2017 and was elected Chairman of the Board of

Directors following the acquisition of Corporate Holdings Limited in August

2018. Mr Bugo is a graduate of the University of Canterbury, Christchurch,

where he obtained Master of Commerce degree in Business

Administration. He has business experience in several sectors including

property development, oil and gas services, automotive importing and

distribution, insurance broking and tourism.

Mr Bugo sits on the Board of private and public companies in Malaysia and

New Zealand, is a Trustee of World Wildlife Fund Malaysia and a passionate

supporter of the Tourette’s Association of New Zealand.

BRENT DOUGLAS KING, BCom, CA

Managing Director

Brent Douglas King has been the Managing Director of General Capital

Limited and its subsidiaries since 3 August 2018. Prior to that date, Mr King

was a non-executive Director since 30 September 2011. He was also the

founder and Managing Director of the Dorchester Group of Companies for

seventeen years until he resigned in 2005. He holds a number of public and

private directorships. He has more than twenty-five years’ experience in

financial, investment banking, underwriting, capital raising and accounting

areas and has assisted a number of public and private companies. Brent is

also a member of the New Zealand Institute of Directors.

PAUL WILLIAM ZINGEL Real Estate Agent Licensee, Residential Property

Manager, FinCap Financial Mentor

Non-executive Independent Director

Paul is a real estate professional with extensive property development and

property management experience. He was previously Product Owner and

Director of New Zealand’s first property auction portal, PropFi ® a start-up

real estate technology company that facilitated the sale and purchase of

property through online auctions. Paul has been successfully trading

financial markets for more than twenty years and as a registered Financial

Services Provider, he has managed private investment portfolios and

provided insurance services and financial mentoring throughout his career.

Paul joined the General Capital Board on 1 March 2022.

2

GREGORY STEPHEN JAMES MCom (Hons), CA
Non-executive Independent Director

Greg James is a Senior Partner of Taxation and Mergers and Acquisitions at

Findex, New Zealand’s 5th largest accounting firm. Greg has over 30 years

of tax structuring and consulting experience and is a member of Chartered

Accountants Australia and New Zealand. Prior to joining Findex, Greg

worked for PricewaterhouseCoopers, including spending 8 years working

in Hong Kong and New York. During his career, Greg has worked with

numerous listed and newly listed companies and has extensive experience

sourcing equity and debt funding for clients. Greg has a strong interest in

cricket and is currently a director of Parnell Cricket Club and is on the board

of Remuera Parnell Sports Community Charitable Trust. He is also a

member of China ASEAN and is a director of a number of its group

companies.

MEGAN DOMINIQUE GLEN BCom, BSc

Non-executive Director

Megan is currently a Director in Forsyth Barr’s investment banking team

and was previously a Director with Ascentro Capital Partners and a

manager in the NZ Super Fund’s Direct Investments team. Megan spent

over five years with Credit Suisse’s investment banking group in New York

as part of their Financial Sponsors Group supporting private equity firms

with acquisitions, divestments and refinancing. Megan started her career

at First NZ Capital, now Jarden, advising some of New Zealand’s largest

corporates. Megan is currently a member of the New Zealand Takeovers

Panel and has previously held Board directorships and observer roles for

private companies in New Zealand and Australia.

ANITA MARIA KILLEEN LLB

Non-executive Independent Director

Anita is a Barrister specialising in financial crime and fraud, civil and

criminal litigation, and governance and dispute resolution. Ms Killeen

holds a variety of governance roles in the legal, financial, local

government, education, health and not for profit sectors including having

served as Chair of the Auckland Regional Amenities Funding Board, as

Chair and National President of Fertility New Zealand, as Deputy Chair of

Ngāi Tai ki Tāmaki Commercial Investment Board, Deputy Chair of NetSafe

New Zealand, Independent Director of the Domain Name Commission,

and Director of the SPCA Auckland.

3


General Finance Directors and Executive


DONALD FREDERICK HATTAWAY CA, ACIS

General Finance Limited Chairman and Independent Non-Executive Director


Don is a member of Chartered Accountants Australia and New Zealand

(CAANZ) and practised as a Chartered Accountant in public practice from

1980 until April 2023. He retired as a Partner in Price Waterhouse in 1996

and specialised in acting for small or medium sized enterprise businesses

since then often fulfilling the role of finance director for those companies.

Don was the Chairman of listed banking software technology company

Finzsoft Solutions Ltd. Don is a previous Chairman of the Board of Directors

of the Auckland Cricket Association. He has held a previous public company

directorship with Cooks Coffee Company Ltd (previously known as Cooks

Global Foods Ltd) as well as directorships with a number of private

companies.


GREGORY JOHN PEARCE B.Com.

General Finance Limited Independent Non-Executive Director


Greg is a lending and credit specialist having held roles with large

companies (Telecom and Air New Zealand) and a senior role with

Dorchester Finance Limited being General Manager Lending and Credit

from 1997 to 2008. He subsequently consulted to receivers in relation to

loan recoveries and in 2017 joined General Finance as Executive Director

Lending and Credit. He retired from this role in 2020 and has continued with

the company as an independent Non-Executive Director.







NICK PIMENOV BCom, CA

Chief Financial Officer


Nick is a Chartered Accountant with over 13 years industry experience.

Nick’s background is in audit as well as over 8 years of finance and

commercial experience in large NZ companies (2degrees, Academic

Colleges Group, and Sime Darby Motors).



4

Directors’ Report

The Directors of General Capital Limited (GEN), the NZX listed Financial Services Group, are pleased to present

another record financial result for the year ended 31 March 2024. This year, we have achieved significant

milestones and delivered a strong financial performance, with a 25% increase in revenue to $17.17 million and

a 17% rise in Net Profit After Tax to $2.63 million. These results reflect our dedicated efforts and strategic

initiatives in a challenging and dynamic market environment.


Our total assets have grown by 20%, reaching $163.33 million, underscoring our solid financial foundation.

Despite the prevailing headwinds faced by the New Zealand economy, our commitment to prudent financial

management has enabled us to maintain stability and foster growth. We recognize the vital role of our

stakeholders, whose unwavering support and trust have been instrumental in achieving these results.


On 6 December 2023 Equifax reaffirmed the credit rating of General Finance Limited, a wholly owned subsidiary

of General Capital, as BB with a Stable Outlook. This reaffirmation reflects our robust financial health and our

ability to navigate through regulatory and market changes effectively.


Key Financial Highlights


FY24 (31 Mar 2024) FY23 (31 Mar 2023) Change

Revenue $17,171,443 $13,709,253 +25%

Net Profit After Tax $2,633,161 $2,258,243 +17%

Total Assets $163,330,631 $136,087,859 +20%

Total Equity $26,811,417 $24,252,770 +11%

Net Tangible Assets (NTA) per Share 6.65 cps 5.94 cps +12%





$-

$2,000,000

$4,000,000

$6,000,000

$8,000,000

$10,000,000

$12,000,000

$14,000,000

$16,000,000

$18,000,000

$20,000,000

FY 2020FY 2021FY 2022FY 2023FY 2024

Revenue

5




Strong Management of Arrears, Net Interest Margin and Costs


General Finance, our wholly owned subsidiary, has successfully navigated a challenging economic landscape

through astute financial management. The team has excelled in managing and reducing both credit losses and

arrears, all while maintaining a stable cost-to-income ratio and a robust Net Interest Margin (NIM).


Despite a decrease in NIM, primarily driven by higher prevailing interest rates and a general economic softening,

General Finance's strategic approach ensured strong retention of the margin. Through careful control of credit

losses and arrears, the subsidiary achieved significant reductions, underscoring the effectiveness of its risk

management practices. This prudent strategy not only safeguarded the company's financial stability but also

positioned it well for future growth opportunities.


FY24 (31 Mar 2024) FY23 (31 Mar 2023) Change

NIM (%) 2.90% 4.48% -35%

Credit Losses (%) 0.35% 0.70% -50%

Arrears (%) 0.74% 11.61% -94%

Cost to Income Ratio (%) 56.25% 56.57% -1%


Regulatory Update


The significant regulatory changes being driven by the Deposit Takers Act 2023 and the Deposit Compensation

Scheme (“DCS”) has been a focus of both the Board and Management due to its impact on General Finance.


As a RBNZ regulated non-bank deposit taker General Finance is eligible to apply to be included in the DCS and it

is our intention to do so. The Board and Management believe that, whilst General Finance will be required to

pay a levy to be part of the scheme and be subject to enhanced prudential regulation by the RBNZ, the benefits

of having a guarantee for the first $100,000 of deposits will likely result in a significant net benefit for General

Finance that will drive a significant increase in term deposits once it comes into force in mid-2025 impacting the

2026 financial year and beyond.

$-

$500,000

$1,000,000

$1,500,000

$2,000,000

$2,500,000

$3,000,000

FY 2020FY 2021FY 2022FY 2023FY 2024

Net Profit After Tax

6

Outlook

Looking ahead to the 2025 financial year, we anticipate a continuation of the growth and profitability trends

driven by our strategic initiatives and market conditions. Our priorities include expanding our loan book,

enhancing our research and advisory services, and maintaining strong liquidity. We expect to see further growth

in secured term deposits and a continued focus on sustainable value creation for our shareholders.


Acknowledgements


We would like to express our gratitude to our shareholders, customers, and employees for their continued

support and confidence in General Capital Ltd. We also extend our appreciation to our fellow Directors and

management team for their dedication and hard work.
















Rewi Hamid Bugo Brent Douglas King

Chairman Managing Director


7

Corporate Governance Statement

The Board of Directors (“Board”) and management of General Capital Limited (“the Company”) are committed

to ensuring that the Company adheres to best practice governance principles where practical and maintains the

highest ethical standards. The Board regularly reviews and assesses the Company’s governance structures to

ensure, where practical, that they are consistent, both in form and in substance, with best practice.


Key governance documents that have been adopted by the Company are published on the Company’s website

at www.gencap.co.nz/corporate-governance.


The Board framework and governance practices for the year ended 31 March 2024 was largely compliant with

the requirements of the NZX Code. The Governance Code contains eight (8) principles and various

recommendations for each principle. The Board has reported on the Company’s compliance with each of the

recommendations which are included below.


The Board is reporting against the revised NZX Corporate Governance Code dated 1 April 2023 and the NZX

Corporate Governance Code can be found on the NZX Website at: www.nzx.com/regulation/nzx-rules-

guidance/corporate-governance-code.


Principal 1 – Ethical Standards

"Directors should set high standards of ethical behaviour, model this behaviour and hold management

accountable for these standards being followed throughout the organisation."


RECOMMENDATION 1.1

The board should document minimum standards of ethical behaviour to which the issuer’s directors and

employees are expected to adhere (a code of ethics).


The code of ethics and where to find it should be communicated to the issuer’s employees. Training should

be provided regularly. The standards may be contained in a single policy document or more than one policy.


The code of ethics should outline internal reporting procedures for any breach of ethics, and describe the

issuer’s expectations about behaviour, namely that every director and employee:

(a) acts honestly and with personal integrity in all actions;

(b) declares conflicts of interest and proactively advises of any potential conflicts;

(c) undertakes proper receipt and use of corporate information, assets and property;

(d) in the case of directors, gives proper attention to the matters before them;

(e) acts honestly and in the best interests of the issuer, shareholders and stakeholders and as required by law;

(f) adheres to any procedures around giving and receiving gifts (for example, where gifts are given that are of

value in order to influence employees and directors, such gifts should not be accepted);

(g) adheres to any procedures about whistle blowing (for example, where actions of a whistle blower have

complied with the issuer’s procedures, an issuer should protect and support them, whether or not action is

taken); and

(h) manages breaches of the code


Compliance with recommendation during the year ended 31 March 2024:

The Board has a strong belief that ethical behaviour is paramount to good corporate governance and underpins

the reputation of the Company. As such, the ethical principles that were applied by the Board (and required of

Management and employees) were in line with the recommendations above.


The Group’s code of ethics complies with the recommendation in full. Employees are required to read the code

of ethics. The code of ethics has been published on the Company’s website at www.gencap.co.nz/corporate-

governance.



8

RECOMMENDATION 1.2
An issuer should have a financial product dealing policy which extends to employees and directors.


Compliance with recommendation during the year ended 31 March 2024:

The Board has a financial products trading policy in place for employees and directors. This policy requires prior

approval of all transactions in General Capital Limited quoted securities and other restricted securities, specifies

blackout periods for trading and defines prohibited trading.


The financial products trading policy is included in the Company’s Board Policies and Procedures document

which is published on the Company’s website at www.gencap.co.nz/corporate-governance.


PRINCIPLE 2 – Board Composition & Performance

“To ensure an effective board, there should be a balance of independence, skills, knowledge, experience and

perspectives.”


Board Composition

Board members who have a wide range of business, technical and financial background lead the Company. In

November 2021 the Board adopted a board skills matrix to assist in maintaining a balance ensuring it has a

balance of independence, skills, knowledge, experience and perspectives. The Board believes it complies with

the recommendation.


The Board is responsible and accountable to shareholders and other stakeholders for the Company’s

performance and its compliance with applicable laws and standards.


Directors

As at 31 March 2024 the Board of Directors comprised six directors, five of which are Non-executive Directors

(Rewi Hamid Bugo (Chairman), Paul William Zingel, Gregory Stephen James, Megan Dominique Glen and Anita

Maria Killeen) and one Executive Director (Brent Douglas King).


Paul William Zingel, Gregory Stephen James and Anita Maria Killeen are independent directors of the Company.


Paul William Zingel was appointed as a director effective from 1 March 2022. The Board determined that

notwithstanding his family connection with a significant product holder, there were no particular circumstances

that would materially interfere with his ability to exercise independent judgment and he was identified an

independent director of the Company.


Gregory Stephen James was appointed as a director effective from 28 September 2022. The Board determined

that there were no particular circumstances that would materially interfere with his ability to exercise

independent judgement and he was assessed as an independent director of the Company.


Anita Maria Killeen was appointed as a director effective from 1 February 2024. The Board determined that there

were no particular circumstances that would materially interfere with her ability to exercise independent

judgement and she was assessed as an independent director of the Company.


Megan Dominique Glen was appointed as a director effective from 17 February 2023. Megan Dominique Glen

was not assessed to be an independent director of the Company as she was nominated by API No 1 Limited

Partnership (API) to represent API’s stake in the Company (currently 23.92% of the Company’s ordinary shares)

and her appointment was supported by the Board of Directors.


By virtue of the extent of his significant product holding, Rewi Hamid Bugo has not been assessed as an

independent director of the Company due to shares held directly or indirectly in the Company.


As an executive and significant product holding in the Company, Brent Douglas King has also been assessed as a

non-independent director of the Company.


Refer to the Directors’ Profiles section of this Annual Report for further details.

9


Huei Min Lim resigned as a director with effect from 31 May 2023.


Simon John McArley resigned as a director with effect from 17 July 2023.


Prior to their resignations both Simon John McArley and Huei Min Lin were determined by the Board to be

independent directors as there were no particular circumstances that would materially interfere with their

ability to exercise independent judgement.


Board and Committee Meetings

The Company’s Board meetings are conducted in accordance with proper process. This enables the Board to

peruse any board papers and review any issues to be deliberated at the Board meeting to enable directors to

make informed decisions. A total of eight Board Meetings were held during the financial year under review.

Board attendance has been recorded as follows:


Board Members Board Audit CommiƩee

Rewi Hamid Bugo (Chairman) 8 5

Brent Douglas King 8 N/A

Huei Min Lim 1 1

Simon John McArley 2 2

Paul William Zingel 8 5

Gregory Stephen James 8 5

Megan Dominique Glen 7 N/A


The Board also met whenever necessary to deal with specific matters needing attention between scheduled

meetings.


The gender balance of the Group’s Directors and officers was as follows:



as at 31 March 2024 as at 31 March 2023


Directors Officers* Directors Officers*

Female 2 1 2 1

Male 4 3 5 3

Total 6 4 7 4

*Officers excludes any directors of the Company.


RECOMMENDATION 2.1

The board of an issuer should operate under a written charter which sets out the roles and responsibilities of

the board. The board charter should clearly distinguish and disclose the respective roles and responsibilities

of the board and management.


Compliance with recommendation during the year ended 31 March 2024:

The Board has had in place throughout the year a written Board Charter which sets out the roles and

responsibilities of the Board and management and complies with the recommendation in full.


The Board Charter has been published on the Company’s website at www.gencap.co.nz/corporate-governance.



10

RECOMMENDATION 2.2
Every issuer should have a procedure for the nomination and appointment of directors to the board.


Compliance with recommendation during the year ended 31 March 2024:

The Company’s nomination procedure is included in the Company’s Board Policies and Procedures document

which is published on the Company’s website at www.gencap.co.nz/corporate-governance.


The Board follows the requirements of the NZX Rules as well as the commentary in the NZX Corporate

Governance Code and the requirements of its nomination procedure. In November 2021 the Board also adopted

a board skills matrix to assist when selecting new directors.


RECOMMENDATION 2.3

An issuer should enter into written agreements with each newly appointed director establishing the terms of

their appointment.


Compliance with recommendation during the year ended 31 March 2024:

The Company’s nomination procedure sets out the form of agreement to be used. The Company’s Board Policies

and Procedures document is published on the Company’s website at www.gencap.co.nz/corporate-governance.

Written agreements have been entered into in accordance with the procedure with all directors appointed

during the year.


RECOMMENDATION 2.4

Every issuer should disclose information about each director in its annual report or on its website, including:


a. a profile of experience, length of service, and ownership interests.

b. the director attendance at board meetings; and

c. the board’s assessment of the director’s independence, including a description as to why the board

has determined the director to be independent if one of the factors listed in table 2.4 applies to the

director, along with a description of the interest, relationship or position that triggers the

application of the relevant factor.


Compliance with recommendation during the year ended 31 March 2024:

All of the information detailed in the recommendation is included in the Annual Report and can be found in the

Directors Profiles, Corporate Governance Statement (Principle 2) and Shareholder and Statutory Information

sections.


RECOMMENDATION 2.5

An issuer should have a written diversity policy which includes requirements for the board or a relevant

committee of the board to set measurable objectives for achieving diversity (which, at a minimum, should

address gender diversity) and to assess annually both the objectives and the entity’s progress in achieving

them. An issuer within the S&P/NZX 20 Index at the commencement of its reporting period should have a

measurable objective for achieving gender diversity in relation to the composition of its board, that is to have

not less than 30% of its directors being male and not less than 30% of its directors being female, within a

specified period. An issuer should disclose its diversity policy or a summary of it.


Compliance with recommendation during the year ended 31 March 2024:

The Board recognises the wide-ranging benefits that diversity brings to an organisation.


The Company’s diversity policy is included in the Company’s Board Policies and Procedures document which is

published on the Company’s website at www.gencap.co.nz/corporate-governance. The Board has set gender

diversity targets to have a minimum of 30% female Directors and 30% female management.


The gender composition of the Company’s directors and officers is included above. As at 31 March 2024 33% of

Directors and 25% of Management are female.


11

RECOMMENDATION 2.6
Directors should undertake appropriate training to remain current on how to best perform their duties as

directors of an issuer.


Compliance with recommendation during the year ended 31 March 2024:

The Company’s Board understand their obligations as directors of a publicly listed Company and undertake

training when necessary to remain current on how to best perform their duties. In November 2021 the Board

adopted a board skills matrix to assess training and development needs and have reviewed this during the year

to 31 March 2024.


RECOMMENDATION 2.7

The board should have a procedure to regularly assess director, board and committee performance.


Compliance with recommendation during the year ended 31 March 2024:

Director and Board performance is considered crucial to the success of the Group. The Board has a procedure

for assessing director, board and committee performance which is published on the Company’s website at

www.gencap.co.nz/corporate-governance.


RECOMMENDATION 2.8

A majority of the board should be independent directors.


Compliance with recommendation during the year ended 31 March 2024:

As detailed in the Board Composition section above, three of the six directors have been identified as

independent directors of the Company. Of the 3 remaining directors, 2 are non-executive directors.


Following the resignation of Huei Min Lim with effect from 31 May 2023 the Board did not have a majority of

independent directors. The subsequent resignation of Simon John McArley on 17 July 2023 further reduced the

number of independent directors until the appointment of Anita Maria Killeen on 1 February 2024. The Board

continues to assess the Board composition and will make an appropriate appointment or other adjustment in

due course.


The Board consider that the composition of the Board during the financial year ended 31 March 2024 was

satisfactory to make decisions in the best interests of the entity and its shareholders. In addition to this, the

board charter provides the opportunity for non-executive directors to regularly confer without executive

directors or other senior executives present. Any directors who are conflicted on certain matters are unable to

participate in the decisions made in relation to those matters.


RECOMMENDATION 2.9

An issuer should have an independent chair of the board.


Compliance with recommendation during the year ended 31 March 2024:

The Chair of the Board, Rewi Hamid Bugo, has been assessed as a non-independent director. Whilst this does

not meet the Code recommendation, the Board believes that the current Chair continues to contribute to a

culture of openness and constructive challenge that allows for diversity of views to be considered by the Board.


RECOMMENDATION 2.10

The chair and the CEO should be different people.


Compliance with recommendation during the year ended 31 March 2024:

The Chair and the CEO were different people.


12

Principle 3 – Board Committees
“The board should use committees where this will enhance its effectiveness in key areas, while still retaining

board responsibility.”


Recommendation 3.1

An issuer’s audit committee should operate under a written charter. Membership on the audit committee

should be majority independent and comprise solely of non-executive directors of the issuer. The chair of the

audit committee should be an independent director and not the chair of the board.


Compliance with recommendation during the year ended 31 March 2024:

General Capital Limited has an Audit Committee which as at 31 March 2024 comprised the following non-

executive directors.


Gregory Stephen James (Chair of the Audit Committee, Independent Director)

Paul William Zingel (Independent Director)

Rewi Hamid Bugo (Non-executive Director)


Huei Min Lim resigned as a director with effect from 31 May 2023.


Simon John McArley resigned as a director with effect from 17 July 2023 and Gregory Stephen James was

subsequently appointed Chair of the Audit Committee.


The Audit Committee operates under a written charter and its responsibilities include the following:


1. Ensuring that processes are in place and monitoring those processes so that the board is properly and

regularly informed and updated on corporate financial matters;

2. Recommending the appointment and removal of the independent auditor;

3. Meeting regularly to monitor and review the independent and internal auditing practices;

4. Having direct communication with and unrestricted access to the independent auditor and any internal

auditors or accountants;

5. Reviewing the financial reports and advising all Directors whether they comply with the appropriate laws

and regulations; and

6. Ensuring that the Key Audit Partner is changed at least every 5 years.

The Audit Committee comprises a majority of independent directors and no executive directors. Gregory

Stephen James has a financial background in accordance with the requirements of NZX Listing Rule 2.13.1 as

did Simon John McArley prior to that.


The Company’s Audit Committee Charter has been published on the Company’s website at

www.gencap.co.nz/corporate-governance.


Recommendation 3.2

Employees should only attend audit committee meetings at the invitation of the audit committee.


Compliance with recommendation during the year ended 31 March 2024:

Non-committee members including employees only attend Audit Committee meetings at the invitation of the

Chair of the Audit Committee.


13

Recommendation 3.3
An issuer should have a remuneration committee which operates under a written charter (unless this is carried

out by the whole board). At least a majority of the remuneration committee should be independent directors.

Management should only attend remuneration committee meetings at the invitation of the remuneration

committee.


Compliance with recommendation during the year ended 31 March 2024:

The Board established a Remuneration Committee in the year ended 31 March 2024. Employees only attended

meetings at the invitation of the Board.


The responsibilities included recommending remuneration packages for directors for consideration by

shareholders and to approve Managing Director and senior management remuneration.


A Remuneration Committee was held on the 26

th

of March 2024 and the majority of the committee members

are Independent Directors.


The Company’s remuneration policy is included in the Company’s Board Policies and Procedures document and

the Remuneration Charter is published on the Company’s website at www.gencap.co.nz/corporate-governance.


Recommendation 3.4

An issuer should establish a nomination committee to recommend director appointments to the board (unless

this is carried out by the whole board), which should operate under a written charter. At least a majority of

the nomination committee should be independent directors.


Compliance with recommendation during the year ended 31 March 2024:

Nomination committee responsibilities were dealt with by the full Board during the year ended 31 March 2024.


The Company’s nomination procedure is included in the Company’s Board Policies and Procedures document

which is published on the Company’s website at www.gencap.co.nz/corporate-governance.


Recommendation 3.5

An issuer should consider whether it is appropriate to have any other board committees as standing board

committees. All committees should operate under written charters. An issuer should identify the members of

each of its committees, and periodically report member attendance.


Compliance with recommendation during the year ended 31 March 2024:

Given the size and scale of the Company’s business and the resources available, the Board has not considered it

necessary to have any other board committees during the year. The Board will review this periodically.


Recommendation 3.6

The board should establish appropriate protocols that set out the procedure to be followed if there is a

takeover offer for the issuer including any communication between insiders and the bidder. It should disclose

the scope of independent advisory reports to shareholders. These protocols should include the option of

establishing an independent takeover committee, and the likely composition and implementation of an

independent takeover committee.


Compliance with recommendation during the year ended 31 March 2024:

The company has a written takeover response procedure approved by the Board.


14

PRINCIPLE 4 – Reporting & Disclosure
“The board should demand integrity in financial and non-financial reporting, and in the timeliness and balance

of corporate disclosures.”


Recommendation 4.1

An issuer’s board should have a written continuous disclosure policy.


Compliance with recommendation during the year ended 31 March 2024:

The Company’s Board is committed to keeping investors and the market informed of all material information

about the Company and its performance in line with the NZX listing rules and has done so throughout the period.


The Company’s continuous disclosure policy is included in the Company’s Board Policies and Procedures

document which is published on the Company’s website at www.gencap.co.nz/corporate-governance.


Recommendation 4.2

An issuer should make its code of ethics, board and committee charters and the policies recommended in the

NZX Code, together with any other key governance documents, available on its website.


Compliance with recommendation during the year ended 31 March 2024:

Key governance documents that have been adopted by the Company are published on the Company’s website

at www.gencap.co.nz/corporate-governance.


Recommendation 4.3

Financial reporting should be balanced, clear and objective.


Compliance with recommendation during the year ended 31 March 2024:

The Board is responsible for ensuring that the financial statements give a true and fair view of the financial

position of the Group and have been prepared using appropriate accounting policies, consistently applied and

supported by reasonable judgements and estimates and for ensuring all relevant financial reporting and

accounting standards have been followed.


For the financial year ended 31 March 2024, the Directors believe that proper accounting records have been

kept which enable, with reasonable accuracy, the determination of the financial position of the Company and

the Group and facilitate compliance of the financial statements with the Financial Reporting Act 1993.


The Managing Director and Chief Financial Officer have confirmed in writing to the Board that the Company’s

financial reports present a true and fair view in all material aspects.


RECOMMENDATION 4.4

An issuer should provide non-financial disclosure at least annually, including considering material exposure

to environmental, social sustainability and governance factors and practices. It should explain how

operational or non-financial targets are measured. Non-financial reporting should be informative, include

forward looking assessments, and align with key strategies and metrics monitored by the board.


Compliance with recommendation during the year ended 31 March 2024:

Due to its nature and size the Company did not provide non-financial disclosure during the financial year ended

31 March 2024. The Company is in the early stages of considering how and to what extent it should report on

non-financial information such as environmental, social and governance matters (ESG). The Company does not

currently have a formal ESG reporting framework, however this is being considered by the Board.


15

PRINCIPLE 5 – Remuneration
“The remuneration of directors and executives should be transparent, fair and reasonable.”


Recommendation 5.1

An issuer should have a remuneration policy for the remuneration of directors. An issuer should recommend

director remuneration packages to shareholders for approval in a transparent manner. Actual director

remuneration should be clearly disclosed in the issuer’s annual report.


Compliance with recommendation during the year ended 31 March 2024:

The Company’s remuneration policy which covers directors is included in the Company’s Board Policies and

Procedures document which is published on the Company’s website at www.gencap.co.nz/corporate-

governance.


Actual director remuneration is disclosed in the Shareholder and Statutory Information section of this Annual

Report.


Recommendation 5.2

An issuer should have a remuneration policy for remuneration of executives which outlines the relative

weightings of remuneration components and relevant performance criteria.


Compliance with recommendation during the year ended 31 March 2024:

Remuneration of executives has been determined in line with the process noted under recommendation 3.3

above and in accordance with the Company’s remuneration policy.


The Company’s remuneration policy is included in the Company’s Board Policies and Procedures document

which is published on the Company’s website at www.gencap.co.nz/corporate-governance.


Recommendation 5.3

An issuer should disclose the remuneration arrangements in place for the CEO in its annual report. This should

include disclosure of the base salary, short term incentives and long-term incentives and the performance

criteria used to determine performance-based payments.


Compliance with recommendation during the year ended 31 March 2024:

Information in relation to the remuneration arrangements in place for Brent Douglas King (Managing Director)

are included in the Shareholder and Statutory Information section of this Annual Report.


PRINCIPLE 6 – Risk Management

“Directors should have a sound understanding of the material risks faced by the issuer and how to manage

them. The Board should regularly verify that the issuer has appropriate processes that identify and manage

potential and material risks.”


Recommendation 6.1

An issuer should have a risk management framework for its business and the issuer’s board should receive

and review regular reports. An issuer should report the material risks facing the business and how these are

being managed.


Compliance with recommendation during the year ended 31 March 2024:

The Group is committed to proactively managing risk and this has been the responsibility of the entire Board

with the assistance of the Audit Committee during the period. The Board delegates day to day management of

risks to the Managing Director and the Corporate Counsel. The executive team and senior management are

required to regularly identify the major risks affecting the business and develop structures, practices and

processes to manage and monitor these risks and report regularly to the Audit Committee and Board.


16

The Company’s Risk Management and Compliance framework has been reviewed and approved by the Board in
the year ended 31 March 2024. The Risk Management Programme includes a Risk Management Plan, Group Risk

Register and a Compliance Obligations Register. The Programme is further supported by a number of policies

focusing on various key risks for the Group including credit, liquidity, operational and market risk.


The Group also maintains insurance policies that it considers adequate to meet its insurable risks.


Recommendation 6.2

An issuer should disclose how it manages its health and safety risks and should report on its health and safety

risks, performance and management.


Compliance with recommendation during the year ended 31 March 2024:

The Group operates with a small number of employees in a relatively low health and safety risk office

environment. Despite this, the Board recognises that effective management of health and safety is essential for

the operation of a successful business, and endeavours to prevent harm and promote wellbeing for employees,

contractors and customers.


The Board is responsible for ensuring that the systems used to identify and manage health and safety risks are

fit for purpose, being effectively implemented, regularly reviewed and continuously improved. All new

incidents, near misses, or hazards identified are reported to the Board by the Health and Safety Officer.


PRINCIPLE 7 – Auditors

“The board should ensure the quality and independence of the external audit process.”


Recommendation 7.1

The board should establish a framework for the issuer’s relationship with its external auditors. This should

include procedures:

(a) for sustaining communication with the issuer’s external auditors;

(b) to ensure that the ability of the external auditors to carry out their statutory audit role is not impaired or

could be reasonably be perceived to be impaired;

(c) to address what, if any, services (whether by type or level) other than their statutory audit roles may be

provided by the auditors to the issuer; and

(d) to provide for the monitoring and approval by the issuer’s audit committee of any service provided by the

external auditors to the issuer other than in their statutory audit role.


Compliance with recommendation during the year ended 31 March 2024:

In accordance with the Company’s board charter and Audit Committee charter, the Board in conjunction with

the Audit Committee were responsible for oversight of and communication with the external auditor and

reviewed the quality and cost of the audit undertaken by the Company’s external auditor. The Board in

conjunction with the Audit Committee also assesses the auditor’s independence on an annual basis.


For the financial year ended 31 March 2024, Grant Thornton New Zealand Audit Limited was the external auditor

for the Company. The statutory audit services are fully separated from non-audit services to ensure that

appropriate independence is maintained. The amount of fees paid for audit and other services is identified in

note 16 in the notes to the consolidated financial statements.


Grant Thornton New Zealand Audit Limited has provided the Board with written confirmation that, in their view,

they were able to operate independently during the year.


17

Recommendation 7.2
The external auditor should attend the issuer’s Annual Meeting to answer questions from shareholders in

relation to the audit.


Compliance with recommendation during the year ended 31 March 2024:

Grant Thornton New Zealand Audit Limited is invited to attend the annual meeting, and the lead audit partner

is expected to be available to answer questions from shareholders at that meeting. Grant Thornton New Zealand

Audit Limited attended the annual shareholder meeting.


Recommendation 7.3

Internal audit functions should be disclosed.


Compliance with recommendation during the year ended 31 March 2024:

The Group has internal controls in place including monitoring and checking that internal controls are operating

effectively. Due to its current size, the Board believes that it was uneconomic and unnecessary for the Company

to have a dedicated internal auditor role during the period. The Board will regularly review this position.


Principle 8 – Shareholder Rights & Relations

“The board should respect the rights of shareholders and foster constructive relationships with shareholders

that encourage them to engage with the issuer.”


Recommendation 8.1

An issuer should have a website where investors and interested shareholders can access financial and

operational information and key corporate governance information about the issuer.


Compliance with recommendation during the year ended 31 March 2024:

Financial statements, NZX announcements and Directors’ profiles are included on the website at

www.gencap.co.nz. Key governance documents that have been adopted by the Company are published on the

Company’s website at www.gencap.co.nz/corporate-governance.


Recommendation 8.2

An issuer should allow investors the ability to easily communicate with the issuer, including by designing its

shareholder meeting arrangements to encourage shareholder participation and by providing shareholders the

option to receive communications from the issuer electronically.


Compliance with recommendation during the year ended 31 March 2024:

The Company held a purely physical annual shareholder meeting in 2023. The Board will continue to assess

whether to use a hybrid meeting format in the future taking into account shareholder feedback. All shareholders

are given the option to elect to receive electronic communications from the Company.


Recommendation 8.3

Quoted equity security holders should have the right to vote on major decisions which may change the nature

of the company in which they are invested in.


Compliance with recommendation during the year ended 31 March 2024:

Shareholders have been given the right to vote on all major decisions in line with the NZX Rules during the year

ended 31 March 2024.


18

Recommendation 8.4
If seeking additional equity capital, issuers of quoted equity securities should offer further equity security

holders of the same class on a pro rata basis and on no less favourable terms, before further equity securities

are offered to other investors.

Compliance with recommendation during the year ended 31 March 2024:

During the year ended 31 March 2024 no capital raising activities were undertaken.

Should the directors of the Company seek additional capital raising in the future they will consider whether the

offer will be extended to all shareholders at that time.

Recommendation 8.5

The board should ensure that the notices of annual or special meetings of quoted equity security holders is

posted on the issuer’s website as soon as possible and at least 20 working days prior to the meeting.

Compliance with recommendation during the year ended 31 March 2024:

The Board encourages shareholder participation in meetings and understands that shareholders need sufficient

time to consider information prior to meetings. The notice of the 2023 annual meeting and extraordinary

meeting was posted on the Company’s website more than 20 working days prior to the meeting.

19

Grant Thornton New Zealand Audit Limited
L4, Grant Thornton House

152 Fanshawe Street

PO Box 1961

Auckland 1140

T +64 9 308 2570

www.grantthornton.co.nz

Chartered Accountants and Business Advisers

Member of Grant Thornton International Ltd.

To the Shareholders of General Capital Limited

Report on the Audit of the Consolidated Financial Statements

Opinion

We have audited the consolidated financial statements of General Capital Limited (the “Company”) and its subsidiaries

(together the “Group”) on pages 24 to 55 which comprise the consolidated statement of financial position as at 31 March 2024,

and the consolidated statement of comprehensive income, consolidated statement of changes in equity and the consolidated

statement of cashflows for the year then ended, and notes to the consolidated financial statements, including material

accounting policy information.

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the financial position

of General Capital Limited as at 31 March 2024 and its financial performance and cash flows for the year then ended in

accordance with New Zealand equivalents to International Financial Reporting Standards (“NZ IFRS”) issued by the New

Zealand Accounting Standards Board.

Basis for Opinion

We conducted our audit in accordance with International Standards on Auditing (New Zealand) (ISAs (NZ)) issued by the New

Zealand Auditing and Assurance Standards Board. Our responsibilities under those standards are further described in the

Auditor’s Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are independent of

the Group in accordance with Professional and Ethical Standard 1 International Code of Ethics for Assurance Practitioners

(including International Independence Standards) (New Zealand) issued by the New Zealand Auditing and Assurance

Standards Board and the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional

Accountants (including International Independence Standards) (IESBA Code), and we have fulfilled our other ethical

responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have

obtained is sufficient and appropriate to provide a basis for our opinion.

Other than in our capacity as auditor and the provision of other assurance services, we have no relationship with, or interests

in, the Group.

Key Audit Matters

Key audit matters are those matters that, in our professional judgement, were of most significance in our audit of the

consolidated financial statements of the current period. These matters were addressed in the context of our audit of the

consolidated financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on

these matters.

Independent Auditor’s Report

20

Chartered Accountants and Business Advisers
Member of Grant Thornton International Ltd.

Why the audit matter is significant How our audit addressed the key audit matter

Allowance for impairment losses from loan

receivables

The allowance for impairment losses from loan

receivables to customers amounts to $472,500 in the

financial statements as at 31 March 2024.

The assessment of the allowance for impairment losses

(expected credit losses) is complex and requires

significant judgement and estimation. Key areas of

judgment included the identification of loans with an

increase in credit risk and assumptions used in the credit

loss model, for both the 12 month and lifetime expected

credit losses.

This was a key audit matter due to the significance of the

judgements and estimates applied in determining the

allowance for impairment losses from loan receivables on

the financial statements.

The principles for determining the allowance for

impairment losses from loan receivables are described in

note 4.1 and the review of the allowance for impairment

losses is disclosed in note 6 of the consolidated financial

statements.

We have:

•Obtained an understanding of the lending processes and

controls and models used to determine the allowance for

impairment losses from loan receivables, including event

identification, collateral valuation and how management’s

estimates and judgements are determined.

•For a selection of loans issued by the Company, we

inspected the loan agreement and other available

information that formed part of management’s loan

approval process (such as credit scores and security

details), and reviewed management’s approval process

controls, to determine whether loans were appropriately

approved and that the information available supported

any conclusions reached about the expected credit loss

at that point.

•We identified loans for which we believed there may be

indicators of impairment. We considered management’s

conclusions regarding impairment for each of these loans

individually.

•For each significant identified loan with indicators of

impairment, we tested whether there was adequate

security against each advance in order to recover the

outstanding balance. Where provided, we considered

adequacy of third-party valuations, and also verified any

prior ranking securities to independent sources.

•For the collective provisioning model, we:

(a)Recalculated the provision based on the input

factors identified by management as part of the

expected credit loss methodology; and

(b)Assessed the calculation of the expected credit

losses model against the requirements of NZ IFRS 9

Financial Instruments for the recognition and

measurement of 12 month and lifetime expected

credit losses on financial assets; and

(c)Assessed the judgements made by management

regarding the assumptions used for the expected

credit loss methodology, including challenging the

appropriateness of current and future external

factors.

•We assessed the appropriateness of the Group

disclosures in the financial statements against the

requirements of the accounting standards.

Impairment assessment of goodwill and other

indefinite life intangible assets

The Group has goodwill of $1,813,589 in the

consolidated financial statements as at 31 March 2024.

We have:

•Obtained an understanding of the Group’s internal

controls relevant to the accounting estimates used to

21

Chartered Accountants and Business Advisers
Member of Grant Thornton International Ltd.

Why the audit matter is significant How our audit addressed the key audit matter

This matter was considered to be one of the areas which

had the greatest impact on our overall audit as:

•annual impairment tests involve complex and

subjective estimation and judgement by

Management on the future performance of the cash

generating units (CGU’s), discount rates applied to

the future cashflow forecasts and future market and

economic conditions. Change in assumptions and

the methodology applied may have a material

impact on the measurement of the impairment of

goodwill and other indefinite life intangible assets.

Management has completed the annual impairment test

for each of the two CGU’s as at 31 March 2024, and the

measurement of each CGU’s recoverable amount

includes the assessment and calculation of its ‘value-in-

use’.

The principles for determining and analysing the

impairment of goodwill and other indefinite life intangible

assets are described in note 4.2 and the review of the

accumulated impairment is disclosed in note 10 of the

consolidated financial statements.

determine the recoverable value of the Group’s CGU’s

and assessed for reasonableness.

•Evaluated Management’s determination of the Group’s

CGUs based on our understanding of the nature of the

Group’s business and the economic environment in

which the segments operate.

•Challenged Management’s assumptions and estimates

used to determine the recoverable value of its material

indefinite life intangible assets, including those relating to

forecasted revenue, expenditure and discount rates

applied.

•Evaluated the logic of the value-in-use calculations

supporting Management’s annual impairment test and

testing the mathematical accuracy of these calculations.

•Evaluated Management’s process regarding the

preparation and review of forecast financial statements

(statement of financial position, statement of

comprehensive income, and cash flow statement),

including comparing forecasts to Board approved

forecasts, and evaluating the historical accuracy of the

Group’s forecasting to actual historical performance.

•Engaged our own internal valuation experts to evaluate

the logic of the value-in-use calculation and the inputs to

the calculation of the discount rates applied, including

evaluating the forecasts, inputs and any underlying

assumptions with a view to identifying Management bias.

•Performed our own sensitivity analyses for reasonably

possible changes in key assumptions, the two main

assumptions being: the discount rate and forecast growth

assumptions.

•Evaluated the related disclosures (including the

accounting policies and accounting estimates) around

goodwill and other indefinite life intangible assets, which

are included in the Group’s consolidated financial

statements.

Information Other than the Consolidated Financial Statements and Auditor’s Report thereon

The Directors are responsible for the other information. The other information comprises the information included in the

Company’s Annual Report but does not include the consolidated financial statements and our auditor’s report thereon.

Our opinion on the consolidated financial statements does not cover the other information and we do not express any form of

audit opinion or assurance conclusion thereon.

In connection with our audit of the consolidated financial statements, our responsibility is to read the other information and, in

doing so, consider whether the other information is materially inconsistent with the consolidated financial statements, or our

knowledge obtained in the audit or otherwise appears to be materially misstated. If, based on the work we have performed, we

conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to

report in this regard.

22

Chartered Accountants and Business Advisers
Member of Grant Thornton International Ltd.

Directors’ responsibilities for the Consolidated Financial Statements

The Directors are responsible on behalf of the Group for the preparation and fair presentation of the consolidated financial

statements in accordance with New Zealand equivalents to International Financial Reporting Standards issued by the New

Zealand Accounting Standards Board, and for such internal control as the Directors determine is necessary to enable the

preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, the directors are responsible on behalf of the Group for assessing the

Group’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going

concern basis of accounting unless the directors either intend to liquidate the Group or to cease operations, or have no

realistic alternative but to do so.

Auditor’s responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free

from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion.

Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs

(NZ) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered

material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users

taken on the basis of these consolidated financial statements.

A further description of the auditor’s responsibilities for the audit of the consolidated financial statements is located on the

External Reporting Board’s website at: https://www.xrb.govt.nz/assurance-standards/auditors-responsibilities/audit-report-1/

Restriction on use of our report

This report is made solely to the Company’s shareholders, as a body. Our audit work has been undertaken so that we might

state to the Company’s shareholders, as a body, those matters which we are required to state to them in an auditor’s report

and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other

than the Company and the Company’s shareholders, as a body, for our audit work, for this report or for the opinion we have

formed.

Grant Thornton New Zealand Audit Limited

Ryan Campbell

Partner

Auckland

26 June 2024

23

20242023
Note$$

Interest income

9

13,679,143 10,618,423

Interest expense

9

(8,096,442) (5,223,799)

Net interest income

5,582,701 5,394,624

Fee and commission income

9

3,327,444 2,980,148

Fee and commission expense

9

(862,307) (781,120)

Net fee and commission income

2,465,137 2,199,028

Revenue from contracts with customers

9

138,466 65,626

Cost of sales

9

(17,426) (4,006)

Gross profit from contracts with customers

121,040 61,620

Other income

9

26,390 45,056

Gross Profit

8,195,268 7,700,328

Increase in allowance for expected credit losses

(59,087) (573,970)

Personnel expenses

(1,791,560) (1,218,362)

Occupancy expenses

(105,378) -

Depreciation

(11,313) (125,797)

Amortisation and impairment of intangible assets

10

(21,334) (537,779)

Other operating expenses

(2,620,994) (1,900,329)

(4,609,666) (4,356,237)

Profit before income tax expense

3,585,602 3,344,091

Income tax expense

17

(952,441) (1,085,848)

Net profit after income tax expense

2,633,161 2,258,243

Other comprehensive income

Items that will not be reclassified to profit or loss

13(b)

(31,240) (73,713)

Income tax on these items

(43,273)

-

Other comprehensive loss for the year, net of tax (74,513) (73,713)

Total comprehensive income

2,558,648 2,184,530

Earnings per share (cents per share)

14

0.72 0.98

Diluted earnings per share (cents per share)

14

0.72 0.98

The accompanying notes are an integral part of these financial statements.

GENERAL CAPITAL LIMITED

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE YEAR ENDED 31 MARCH 2024

Changes in the fair value of equity investments at fair value

through other comprehensive income

24

GENERAL CAPITAL LIMITED
20242023

Note$$

Equity

Share capital

13(a)

21,561,120 21,561,120

Accumulated earnings 5,381,065 3,011,160

Reserves

13(b)

(130,768) (319,510)

Total equity

26,811,417 24,252,770



Assets

Cash and cash equivalents

5

15,303,073 14,072,194

Accounts receivables 4,850 46,213

Related party receivables

19

235 725

Other current assets 334,828 347,467

Bank deposits

5

12,714,591 9,937,974

Loan receivables

6

132,163,725 108,771,965

Property, plant and equipment 31,907 33,732

12

126,624

214,730

Deferred tax asset

17.2

182,173 313,454

Intangible assets and goodwill

10

2,468,625 2,349,405

Total assets

163,330,631 136,087,859

Liabilities

Accounts payable and other payables 1,033,694 816,766

Related party payables

19

6,366 117,410

Term deposits

7

135,118,547 109,886,032

Income tax payable 360,607 1,014,881

Total liabilities

136,519,214 111,835,089

Net assets

26,811,417 24,252,770

The accompanying notes are an integral part of these financial statements.

Net tangible assets (NTA) per share (cents per share) 6.65 5.94

Net assets (NA) per share (cents per share) 7.37 6.67

The financial statements are signed on behalf of the Board.

Rewi Bugo Brent King

ChairmanManaging Director

Authorised for issue on:25-Jun-24

Investments

AS AT 31 MARCH 2024

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

25

GENERAL CAPITAL LIMITED
Note$$$$

13,025,575 (245,799) 752,916 13,532,692

- - 2,258,243 2,258,243

13(b)

- (73,713) - (73,713)

- (73,713) 2,258,243 2,184,530

8,535,545 - - 8,535,545

8,535,545 - - 8,535,545

21,561,120 (319,511) 3,011,160 24,252,769

- - 2,633,161 2,633,161

- (74,513) - (74,513)

- (74,513) 2,633,161 2,558,648

263,256 (263,256)

-

21,561,120 (130,768) 5,381,065 26,811,417

The accompanying notes are an integral part of these financial statements.

Transfer fair value reserve to

accumulated earnings for FVTOCI

equity investment

Total comprehensive income for

the year

Accumulated

earnings

Share capital

Balance at 31 March 2023

Profit for the year

Other comprehensive income for

the year

Contributions of equity net of

transaction costs

Total transactions with owners in

their capacity as owners

Balance at 31 March 2024

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE YEAR ENDED 31 MARCH 2024

Total equity

Profit for the year

Other comprehensive income for

the year

Total comprehensive income for

the year

Transactions with owners in their

capacity as owners:

Reserves

Balance at 1 April 2022

26

GENERAL CAPITAL LIMITED
20242023

Note

$$

Cash flow from operating activities

Interest received

13,795,341 10,647,402

Receipts from customers

3,312,918 2,457,853

Other income

3,190 4,755

Payments to suppliers and employees

(5,419,578) (3,753,310)

Interest paid

(7,377,800) (5,898,226)

Income tax paid

(1,475,434) (772,829)

2,838,637 2,685,645

Term deposits (net receipts)

24,485,709 22,534,413

Loan receivables (net advances)

(23,144,390) (28,665,673)

Net cash provided by / (used in) operating activities 18

4,179,956 (3,445,615)

Cash flow from investing activities

Purchase of property, plant and equipment

(9,488) (11,960)

Purchase of Intangible assets

(213,346) -

Investment in bank deposits

(2,776,617) (7,487,974)

Investment in equities

50,374 -

Net cash used in investing activities

(2,949,077) (7,499,934)

Cash flow from financing activities

Issue of ordinary shares

- 8,535,545

Lease payments

- (179,372)

Net cash provided by financing activities

- 8,356,173

Reconciliation of cash and cash equivalents

14,072,194 16,661,570

1,230,879 (2,589,376)

5

15,303,073

14,072,194


The accompanying notes are an integral part of these financial statements.

Cash and cash equivalents at the end of the reporting year

Net increase / (decrease) in cash and cash equivalents held

during the reporting year

Cash and cash equivalents at the beginning of the reporting

year

CONSOLIDATED STATEMENT OF CASHFLOWS

FOR THE YEAR ENDED 31 MARCH 2024

Net cash flows from operating activities before changes in

operating assets and liabilities

27

NOTE 1: REPORTING ENTITY
The consolidated financial statements were authorised for issue by the directors on 25 June 2024

NOTE 2: BASIS OF PREPARATION

NOTE 3: SIGNIFICANT ACCOUNTING POLICIES

3.1 Revenue and expense recognition

The financial statements are presented in New Zealand dollars which is the Group's functional currency and the presentation currency. Unless

otherwise indicated, amounts in the financial statements have been rounded to the nearest dollar.

GENERAL CAPITAL LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

GeneralCapitalLimited("theCompany")isincorporatedanddomiciledinNewZealand.GeneralCapitalLimitedisregisteredundertheCompanies

Act 1993.

General Capital Limited is a FMC reporting entity for the purposes of the Financial Markets Conduct Act 2013.

The consolidated financial statements of General Capital Limited and its subsidiaries (together "the Group") have been prepared in accordance

with the Companies Act 1993 and the Financial Markets Conduct Act 2013.

The Group is a for profit entity.

The Group's principal activities are:

- Finance (deposit taking and mortgage lending);

- Research and advisory (listing and capital management).

These financial statements have been prepared on a going concern basis, which contemplates continuity of normal business activities and the

realisationofassetsandthesettlementofliabilitiesintheordinarycourseofbusiness,inaccordancewithhistoricalcostconcepts,asmodifiedby

the fair value of certain assets and liabilities as identified in the accounting policies below.

These financial statements have been prepared in accordance with Generally Accepted Accounting Practice in New Zealand ("NZ GAAP"). They

comply with New Zealand Equivalents to International Financial Reporting Standards ("NZ IFRS") and other applicable Financial Reporting

Standards, as appropriate for profit oriented entities. These consolidated financial statements also comply with International Financial Reporting

Standards ("IFRS").

(a) Interest income and expense

Interest income and interest expense

Interestincomeandinterestexpenseisrecognisedinprofit orlossusingtheeffectiveinterestmethod.Theeffectiveinterest methodcalculates

theamortisedcostofafinancialassetorliabilityandallocatestheinterestincomeanddirectlyrelatedfees(includingloanoriginationfees)and

transaction costs (including commission expenses) that are an integral component of the effective interest rate over the expected life of the

financial asset or liability.

Loan fees and commissions

Lendingfeeincome(suchasloanestablishmentfees)thatisintegraltotheeffectiveyieldofaloanheldatamortisedcostiscapitalisedaspartof

theamortisedcostanddeferredoverthelifeoftheloanusingtheeffectiveinterestmethod.Lendingfeesnotdirectlyrelatedtotheoriginationof

a loan (account maintenance fee) are recognised over the period of service. Incremental and directly attributable costs (such as commissions)

associated with the origination of a financial asset (such as loans) and financial liabilities (such as term deposits) are capitalised as part of the

amortised cost and deferred over the life of the financial instrument using the effective interest method.

(b) Revenue from contracts with customers:

Advisory fee revenue

Advisory contracts generally span a period of three months to one and a half years. Management determine the performance obligation(s)

inherent in the contract at contract inception and recognise revenue upon completion of each of the performance obligations. Performance

obligations includeadviceprovidedtothe entityand sometimesinclude thesuccess of a project. There arespecific billingmilestones builtinto

each contract and payment is generally due within 30 to 60 days of the milestone.

Assets and liabilities arising from revenue from contracts with customers

Accounts receivables are non-interest bearing and are generally on terms of 30 to 60 days.

28

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

3.2 Financial instruments

Interest income is recognised using the effective interest method for financial assets measured subsequently at amortised cost.

For financial assets that have subsequently become credit‑impaired, interest income is recognised by applying the effective interest rate to the

amortised cost of the financial asset. If, in subsequent reporting periods, the credit risk on the credit‑impaired financial instrument improves so

that the financial asset is no longer credit


impaired, interest income is recognised by applying the effective interest rate to the gross carrying

amount of the financial asset.

Financial assets at FVTOCI*

Equity Instruments at FVTOCI*

On initial recognition, the Group made an irrevocable election (on an instrument by instrument basis) to designate investments in equity

instruments as at FVTOCI*.

Investments in equity instruments at FVTOCI* are initially measured at fair value plus transaction costs. Subsequently, they are measured at fair

value with gains and losses arising from changes in fair value recognised in other comprehensive income and accumulated in the financial assets at

FVOCI reserve. The cumulative gain or loss is not be reclassified to profit or loss on disposal of the equity investments, instead, it is transferred to

retained earnings.

Financial assets

Allrecognisedfinancialassetsaremeasuredsubsequentlyintheirentiretyateitheramortisedcostorfairvalue,dependingontheclassificationof

the financial assets.

Classification of financial assets

Financial assets that meet the following conditions are measured subsequently at amortised cost:

- the financial asset is held within a business model whose objective is to hold financial assets in order to collect contractual cash flows; and

- thecontractualtermsof thefinancialassetgiverise onspecified datesto cashflows that are solelypayments of principal andinterest onthe

principal amount outstanding.

Financial assets that meet the following conditions are measured subsequently at fair value through other comprehensive income (FVTOCI)*:

-thefinancialassetisheldwithinabusinessmodelwhoseobjectiveisachievedbybothcollectingcontractualcashflowsandsellingthefinancial

assets; and

- thecontractualtermsof thefinancialassetgiverise onspecified datesto cashflows that are solelypayments of principal andinterest onthe

principal amount outstanding.

Despite the foregoing, the Group makes the following irrevocable election/designation at initial recognition of a financial asset:

- the Group irrevocably elects to present subsequent changes in fair value of an equity investment in other comprehensive income if certain

criteria are met; and

- the Group irrevocably designates a financial asset that meets the amortised cost or FVTOCI* criteria as measured at FVTPL** if doing so

eliminates or significantly reduces an accounting mismatch.

TheGroup’sfinancialassetsmeasuredatamortisedcostincludecashandcashequivalents,bankdeposits,tradereceivables,loanreceivables,and

other receivables. The Group’s assets measured at FVTOCI* include investment in equities. The Group has no assets measured at FVTPL**.

*FVTOCI - Fair Value Through Other Comprehensive Income

**FVTPL - Fair Value Through Profit or Loss

The Group has designated all investments in equity instruments as at FVTOCI* on initial recognition.

Initial recognition

Financial assets and financial liabilities are recognised in the Group’s statement of financial position when the Group becomes a party to the

contractual provisions of the instrument.

Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue

offinancialassetsandfinancialliabilitiesareaddedtoordeductedfromthefairvalueofthefinancialassetsorfinancialliabilities,asappropriate,

on initial recognition.

29

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

Stage 1

12-month ECL**(past due 30 days or less)

Stage 2

Lifetime ECL** not credit impaired (between 30 and 90 days past due)

Stage 3

Lifetime ECL** credit impaired (greater than 90 days past due)

Where loans are in default or otherwise credit impaired, ECLs** that result from all possible default events over the life of the loan

are recognised.

*FVTOCI - Fair Value Through Other Comprehensive Income

**ECL - Expected Credit Losses

The nature of the Group’s loan receivables is property lending with a predominant focus on the underlying security value of the loan receivable

(i.e. the residential property value) in the credit assessment. The loans are predominantly advanced on twelve-month terms but range between

three-month and four-year terms. Credit risk information is updated and monitored regularly. Loan receivables are subject to ongoing scrutiny, as

a key component of credit risk management, with reporting of summarised credit risk information to the Group’s directors on at least a monthly

basis.

Irrespective of the outcome of the above assessment, the Group presumes that the credit risk on a financial asset has increased significantly since

initial recognition when contractual payments are more than 30 days past due, unless the Group has reasonable and supportable information that

demonstrates otherwise, for instance when the Group is made aware of a property sale and purchase agreement or refinancing agreement which

provides sufficient evidence that all of the borrower’s obligations including default interest will be met. The Group regularly monitors the

effectiveness of the criteria used to identify whether there has been a significant increase in credit risk and revises them as appropriate to ensure

that the criteria are capable of identifying significant increase in credit risk before the amount becomes past due.

(i) Significant increase in credit risk

In assessing whether the credit risk on a financial asset has increased significantly since initial recognition, the Group compares the risk of a

default occurring on the financial asset at the reporting date with the risk of a default occurring on the financial asset at the date of initial

recognition. In making this assessment, the Group considers its historical loss experience and adjusts this for current observable data. This data

includes any payment defaults by the borrower, known or expected defaults by the borrower on similar obligations (other loans), uninsured

deterioration of the security property and any changes in the borrowers circumstances which could impact on their ability to repay either interest

or principal amounts on their due date. The Group also considers changes or forecast changes to macroeconomic factors including property prices,

unemployment, interest rates, gross domestic product and inflation.

Where there has been a significant increase in credit risk, ECLs** that result from all possible default events over the life of the loan

are recognised.

Modification of financial assets

Whenthecontractualcashflowsofafinancialassetarerenegotiatedorotherwisemodifiedandtherenegotiationormodificationdoesnotresult

inthederecognitionofthatfinancialasset,theGrouprecalculatesthegrosscarryingamountofthefinancialassetandrecognisesamodification

gainorlossinprofitorloss.Thegrosscarryingamountofthefinancialassetisrecalculatedasthepresentvalueoftherenegotiatedormodified

contractual cash flows that are discounted at the financial asset’s original effective interest rate. Any costs or fees incurred adjust the carrying

amount of the modified financial asset and are amortised over the remaining term of the modified financial asset.

Where there has been no evidence of a significant increase in credit risk since initial recognition, ECLs** that result from possible

default events within 12 months are recognised.

Impairment of Financial Assets

The Group recognises a loss allowance for expected credit losses on financial assets that are measured at amortised cost. The amount of expected

credit losses is updated at each reporting date to reflect a significant change in credit risk since initial recognition of the respective financial assets.

The Group recognises lifetime ECL** for trade and other receivables. The expected credit losses on these financial assets are estimated using a

provision matrix based on the Group’s historical credit loss experience, adjusted for factors that are specific to the debtors, general economic

conditions and an assessment of both the current as well as the forecast direction of conditions at the reporting date, including time value of

money where appropriate.

For loan receivables, the Group applies a three-stage approach to measuring ECLs**. Loans may migrate through the following stages based on

their change in credit quality.

30

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

**ECL - Expected Credit Losses

(iv) Write


off policy

TheGroupwritesoffafinancialassetwhenthereisinformationindicatingthattheborrowerisinseverefinancialdifficultyandthereisnorealistic

prospectofrecovery,forexampleanunsecuredfinancialassetwherebytheborrowerhasnorealisticabilitytomeettheirfinancialobligationsto

theGroup.FinancialassetswrittenoffmaystillbesubjecttoenforcementactivitiesundertheGroup’srecoveryprocedures,takingintoaccount

legal advice where appropriate. Any recoveries made are recognised in profit or loss.

(iii) Credit


impaired financial assets

Afinancialassetiscredit‑impairedwhenoneormoreeventsthathaveadetrimentalimpactontheestimatedfuturecashflowsofthatfinancial

asset have occurred. Evidence that a financial asset is credit‑impaired includes observable data about the following events:

a) an increase in loan to valuation ratio caused by either declining property security values or increases in the loan balance;

b) significant financial difficulty of the borrower; and

c) a breach of contract, such as a default or past due event (see (ii) above).

Derecognition of financial assets

The Group derecognises a financial asset only when the contractual rights to the cash flows from the asset expire.

On derecognition of a financial asset measured at amortised cost, the difference between the asset’s carrying amount and the sum of the

consideration received and receivable is recognised in profit or loss.

*LVR - Loan to Valuation Ratio

(ii) Definition of default

The Group considers that default has occurred when a financial asset is more than 90 days past due unless the Group has reasonable and

supportable information to demonstrate that a more lagging default criterion is more appropriate, for instance when the Group is made aware of

a property sale and purchase agreement or refinancing agreement which provides sufficient evidence that all of the borrower’s obligations

including default interest will be met.

If the Group has measured the loss allowance for a financial asset at an amount equal to lifetime ECL** in the previous reporting period, but

determinesatthecurrentreportingdatethattheconditionsforlifetimeECL**arenolongermet, theGroupmeasuresthelossallowanceatan

amount equal to 12‑month ECL** at the current reporting date.

TheGrouprecognisesanimpairmentgainorlossinprofitorlossforallfinancialassetswithacorrespondingadjustmenttotheircarryingamount

through a loss allowance account.

v) Measurement and recognition of expected credit losses

Themeasurementofexpectedcreditlossesisafunctionoftheprobabilityofdefault,lossgivendefault(i.e.themagnitudeofthelossifthereisa

default) andtheexposure atdefault.Theassessment of theprobabilityof default andlossgivendefaultisbasedonhistoricaldata adjustedfor

forward‑lookinginformationincludingmacroeconomicfactorsasdescribedabove.GiventheGroup’sloanbookisallsecuredover property,the

single most significant factor for loss given default is the value of the security property, any known or expected uninsured deterioration of the

property, or any forecast reduction in property values.

As for the exposure at default, for financial assets, this is represented by the assets’ gross carrying amount at the reporting date.

For financial assets, the expected credit loss is estimated as the difference between all contractual cash flows that are due to the Group in

accordance with the contract and all the cash flows that the Group expects to receive, discounted at the original effective interest rate. In

instances where the probability of default has increased significantly (a significant increase in credit risk), or where the loan is in default, the

expectedcreditloss(orlossgivendefault)maynotincreasesignificantlyduetotheGroup’slendingcriteriawhichprohibitslendingwhentheloan

to valuation ratio (LVR)* exceeds 75%.

This meansin generalthat theGroup expectsthat thepresent valueof expectedcash flowsfrom aloan indefault toapproximate thecarrying

valueoftheloanpriortothedefaultevent,exceptincaseswheretheLVR*hasincreasedconsiderablyduetoareductioninthesecurityproperty

valuation or a significant increase in the loan balance.

31

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

3.3 Cash and cash equivalents

3.4 Intangible assets

3.5 Taxation

Financial Liabilities

Classification of Financial Liabilities

Financial liabilities are measured at amortised cost.

Atinitialrecognitionfinancialliabilitiesaremeasuredatfairvalueplustransactioncoststhataredirectlyattributabletotheissueofthefinancial

liabilities. The amortised cost of a financial liability is the amount at which the financial liability is measured at initial recognition minus the

principalrepayments,plusthecumulativeamortisationusingtheeffectiveinterestmethodofanydifferencebetweenthatinitialamountandthe

maturity amount.

The effective interest method is a method of calculating the amortised cost of a financial liability and of allocating interest expense over the

relevantperiod.Theeffectiveinterestrateistheratethatexactlydiscountsestimatedfuturecashpayments(includingallfeesandpointspaidor

receivedthatformanintegralpartoftheeffectiveinterestrate,transactioncostsandotherpremiumsordiscounts)throughtheexpectedlifeof

the financial liability, or (where appropriate) a shorter period, to the amortised cost of a financial liability.

The Group's financial liabilities measured at amortised cost include other payables, term deposits and lease liability. The Group derecognises

financialliabilitieswhen,andonlywhen,theGroup’sobligationsaredischarged,cancelledorhaveexpired.Thedifferencebetweenthecarrying

amount of the financial liability derecognised and the consideration paid and payable is recognised in profit or loss.

Cashand cashequivalents includesdemand deposits with anoriginal term of lessthan or equal to3 months which areconsidered highlyliquid

investments that are readily convertible into cash and used by the Group as part of day-to-day cash management.

Intangible assets comprise goodwill, acquired licences, Bartercard trade dollars, computer software, and customer relationship.

Goodwill and acquired licences are indefinite life intangibles subject to annual impairment testing. Goodwill is allocated to cash-generating units

for the purpose of impairment testing. The allocation is made to those cash-generating units or groups of cash-generating units that are expected

to benefit from the business combination in which the goodwill arose, identified according to the respective operating segment. Refer to note 4.2

and note 10.

Bartercard Trade Dollars are units of electronic currency held by the Group which can be used to pay for products and services from other

Bartercard members instead of paying in cash. They are non-monetary assets which are classified as indefinite life intangible assets. The assets are

recognised at cost less accumulated impairment losses. The trade dollars are acquired as earned and consumed as utilised and are tested at least

annually for impairment or when indication of an impairment exist. An impairment loss is recognised whenever the carrying amount of a

Bartercard exceeds its recoverable amount. The estimated recoverable amount of intangible assets - Bartercard Trade Dollars are the greater of

their fair value less costs to sell or value in use. Trade debits arising from sales to customers and trade credits from purchases of services are

recognised in the statement of comprehensive income in the period in which the transaction occurs. Where trade credits are used to purchase an

asset, the asset is capitalised and recognised in the statement of financial position.

Computer software is recognised in the statement of financial position at cost less accumulated amortisation and impairment losses. Direct costs

associated with the purchase and installation of software licences and the development of software for internal use are capitalised where project

success is probable and the capitalisation criteria is met. Cost associated with planning and evaluating computer software and maintaining a

system after implementation are expensed. Computer software costs are amortised on a straight-line basis (three years).

Income tax for the period comprises current and deferred tax. Current and deferred tax are recognised as an expense or income in the profit or

loss, except when they relate to items that are recognised outside profit or loss (whether in other comprehensive income or directly in equity), in

which case the tax is also recognised outside profit or loss.

Customer relationship is recognised in the statement of financial position at cost less accumulated amortisation and impairment losses. Direct

costs associated with the purchase are capitalised to the cost. Customer relationship cost is amortised on a straight-line basis (five years).

Licences acquired as part of business combinations are capitalised separately from goodwill as intangible assets if their value can be measured

reliably on initial recognition and it is probable that the expected future economic benefits that are attributable to the asset will flow to the

Group.

32

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

3.6 Impairment of non-financial assets

3.7 Standards and interpretations to published standards that are not yet effective

NOTE 4: SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGMENTS

4.1 Allowance for expected credit losses

Calculation of loss allowance

When measuring ECL the Group uses reasonable and supportable forward-looking information, which is based on assumptions for the future

movement of different economic drivers and how these drivers will affect each other.

Loss given default is an estimate of the loss arising on default. It is based on the difference between the contractual cash flows due and those that

the Group would expect to receive, taking into account cash flows from collateral and integral credit enhancements.

Probability of default is an estimate of the likelihood of default over a given time horizon, the calculation of which includes historical data,

assumptions and expectations of future conditions.

Significant increase in credit risk

Expectedcreditlosses(‘ECL’)aremeasuredasanallowanceequalto12-monthECL,orlifetimeECLforassetswithasignificantincreaseincredit

riskorindefaultorotherwisecreditimpaired.Inassessingwhetherthecreditriskofanassethasincreasedsignificantly,theGroupconsidersits

historical loss experience and adjusts this for current observable data. This data includes any payment defaults by the borrower, known or

expected defaultsby theborrower onsimilar obligations(other loans), uninsured deteriorationof thesecurity propertyand anychanges inthe

borrowers circumstances which could impact on their ability to repay either interest or principal amounts on their due date. The Group also

considerschangesorforecastchangestomacroeconomicfactorsincludingpropertyprices,unemployment,interestrates,grossdomesticproduct

and inflation.

Expected credit losses:

1) Based on the history of the Group’s loan book over the last three years, the average annual write-offs as a percentage of the average

loan

receivable balance over the same period was 0.10%.

2) The Group has concluded that adopting a more conservative estimate of 0.25% (March 2023: 0.25%) of the gross loan balance is a more

prudentandappropriatemeasureforanticipatingpotentiallossesoverthenext12months,comparedtoalessconservativeestimateof0.10%.

This approach aligns with the Group's risk management strategy and ensures a more robust provisioning for expected credit losses.

3) Lifetime ECL’s for loans with a significant increase in credit risk and for loans in default have been calculated based on the

Company’s

expectations for discounted net cash flows from the respective loan receivables over the expected remaining life of the loans.

Intangible assets that have an indefinite useful life are not subject to amortisation and are tested for impairment annually or more frequently if

events or changes in circumstances indicate that they might be impaired. Intangible assets not yet available for use are tested for impairment

annually or more frequently if events or changes in circumstances indicate that they might be impaired.

A number of new standards and amendments to standards and interpretations are issued but not yet effective. None of these are expected to

have a significant effect on the financial statements of the Group.

There are a number of significant accounting treatments which include complex or subjective judgments and estimates that may affect the

reported amounts of assets in these financial statements. Estimates and judgments are continually evaluated and are based on historical

experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

An explanation of the judgments and estimates made by the Group in the process of applying its accounting policies, that have the most

significant effect on the amounts recognised in the financial statements, are set out below.

33

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

4.2 Impairment analysis of goodwill and other indefinite life intangible assets

NOTE 5: CASH AND CASH EQUIVALENTS AND BANK TERM DEPOSITS

20242023

$$

Bank call deposits

1

15,303,073 12,683,613

Bank term deposits

2

- 1,388,581

15,303,073 14,072,194

Bank term deposits

2

- Current Portion

3

12,714,591 9,937,974

Interest Rates:

1

Bank call deposits: Between 0.00% and 5.70% (March 2023: Between 0.00% and 4.10%).

2

Bank term deposits: N/A (March 2023: 3.35% - 5.15% per annum).

3

Current Portion of Bank term deposits is contractually repayable within 12 months.

NOTE 6: LOAN RECEIVABLES

20242023

$$

First mortgage advances

134,140,905 110,506,174

Less deferred fee income and expenditure

(1,504,680) (957,944)

Less impairment allowance

(472,500) (776,265)

Net carrying value

132,163,725 108,771,965

Current portion

94,940,875 107,648,114

Non-current portion

37,222,850 1,123,851

132,163,725 108,771,965

*CGU - Cash Generating Unit

Impact of high inflation, high interest rates, uncertainty in the property market, financial market uncertainties on loan receivables and

expected credit losses on impairment analysis of goodwill and other indefinite life intangible assets

When conducting the impairment analysis of goodwill and other indefinite-life intangible assets, the Group has considered all reasonably known

and available information.

Expected impact on cash-generating units

1. Finance CGU* - The forecasted cash flows used in the impairment analysis factor in the above-stated events. The results of the model show that

there is still significant headroom in the unit.

2. Research and Advisory CGU* - Due to the impacts of some of the above-stated factors the Group performed an impairment test as at 31 March

24 which has resulted in no impairment to the CGU*.

Thecarryingvalueofgoodwillandindefinitelifeintangibleassets(includinglicencesandBartercardtradedollars)isassessedatleastannuallyto

ensurethatitisnotimpaired.WithregardtoGoodwillandLicences,performingthisanalysisrequiresmanagementtoestimatefuturecashflows

to be generated by the cash-generating unit, which entails making judgements, including the expected rate of growth of revenues and

expenditures, assetsandliabilities, andtheresultingcashflows.Judgements alsoneedtobemadeabouttheappropriatediscount ratetoapply

when valuing future cash flows.

A sensitivity analysis performed by Management has highlighted that the carrying value of the Goodwill and other assets in the research and

advisory CGU* are highly reliant on the achievement of revenue forecasts from advisory projects.

Managementhaveperformedafair valueless costsof disposalimpairment test in relationto thecarrying valueof theBartercard tradedollars

asset at 31 March 2024.

34

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

Primary loan security - first mortgage2024202420232023

$%$%

Residential housing

117,504,757

87.6%

92,916,572

84.1%

Residential bare land

14,911,604

11.1%

12,383,593

11.2%

Residential development land and housing

-

0.0%

2,107,329

1.9%

Commercial property

1

1,724,544

1.3%

3,098,680

2.8%

134,140,905 100.0% 110,506,174 100.0%

Interest rate: Between 9.25% and 11.50% (2023: Between 5.45% and 12.90%).

Effective interest rate: Between 10.25% and 24.11% (2023: Between 5.79% and 22.79%).

For loans that are in default, additional interest of up to 10% is charged.

Borrower payment terms are profiled as follows:

20242023

$$

Principal and interest paid monthly

1,144,796 -

Interest only paid monthly

132,683,098 110,401,835

Interest capitalised

313,011 104,339

Total loan receivables

134,140,905 110,506,174

20242023

$$

Interest income

13,246 236,135

Loan Fees

2,853,522 2,629,760

Total

2,866,768 2,865,895

Sometimesloanrepaymentsdonotoccuronthecontractualmaturitydateandthetermoftheloanisextendedi.e.rolloveroccurs.Beforealoan

isrolledover,theCompany’sstandardcreditcheckingandapprovalprocessesarere-applied. Thecurrent“loantosecurityvalue”positionwillbe

re-assessedandupdatedvaluationsareobtainedwheretheDirectorsconsiderthisappropriate.Loanapplicationfeesarechargedandevidenceis

obtained of the borrower’s agreement to the contractual terms and conditions of the extended loan.

Loan receivables represent loans at commercial interest rates. Current loan receivables are contractually repayable within 12 months. Non-

current loan receivables are contractually repayable within 12 months to 36 months of reporting date.

At year end there was $2,052,306 in outstanding loan commitments (loans approved and accepted not yet drawn) including future capitalised

interest (March 2023: $7,510).

Loan fees (for all loans) and interest (for capitalised interest loans) are capitalised to the loan balances when charged and recognised over the life

of the loans using the effective interest method. The associated cash is received when the loans are repaid (or partially repaid). Income recognised

during the financial year from amounts capitalised to loan receivables were as follows:

Atreportingdate,30.8%(March2023:28.6%)ofloansbynumberand32.6%(March2023:24.8%)byvaluerepresentloansthathavebeenrolled

overandareintotheirsecondorsubsequentcreditperiods.Whereloanshavebeenrolledover,theirclassificationintheseconsolidatedfinancial

statementsascurrentornon-current,oraspastdue,isbasedonpaymentduedatesasperthetermsoftheextendedcontract,andnotasperthe

original or preceding contract.

1

The Group’s lendingpolicy allows for a maximum of 30% of total lendingto besecured over commercial properties.During theyear ended31

March 2024 the Group had 1.3% of commercial lending (2023: 2.8%).

The core lending activity of the Group is providing, through a broker network, short term and bridging finance secured by mortgage over

residentialproperty. Themajorityofloansareenteredintowithamaturitydatewithin12months,withaproposalthatrepaymentwillbefunded

bythesaleofthesecuredpropertyorthroughrefinancingbytheborrower.GeneralFinanceLimitedlendingpolicyallowsforamaximum“loanto

securityvalue”of75%(excludingfeesandcharges)onadvances,unlessapprovedbythefullboardofGeneralFinanceLimited.Therearenoloans

with loan to valuation ratio above 75% at the reporting date (2023: none).

35

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

Reconciliation of gross loan receivable balance movements through ECL* stages:

Lifetime ECL* Lifetime ECL*

12 month not creditcredit

ECL*impaired impairedTotal

$$$$

Balance as at 31 March 2022

79,129,017 1,301,738 487,279 80,918,034

New loan advances

95,678,186 - - 95,678,186

Repayments

(64,301,029) (1,301,738) (487,279) (66,090,046)

Transfer to lifetime not credit impaired

(5,415,857) 5,415,857 - -

Transfer to lifetime credit impaired

(4,061,846) - 4,061,846 -

Balance as at 31 March 2023

101,028,471 5,415,857 4,061,846

110,506,174

New loan advances

111,138,453 - - 111,138,453

Repayments

(78,255,053) (5,053,005) (3,832,813) (87,140,871)

Loan balances written off

- (362,852) - (362,852)

Transfer to lifetime not credit impaired

(7,780,334) 7,780,334 - -

Transfer to lifetime credit impaired

(573,671) - 573,671 -

Balance as at 31 March 2024

125,557,867 7,780,334 802,704 134,140,905

Reconciliation of movements in impairment allowance by stage:

Lifetime ECL* Lifetime ECL*

12 month not creditcredit

ECL*impaired impairedTotal

$$$$

Balance as at 31 March 2022

197,536 3,254 1,505 202,295

New loan advances

239,195 - - 239,195

Repayments

(160,466) (3,254) (1,505) (165,225)

Transfer to lifetime not credit impaired

(13,540) 13,540 - -

Transfer to lifetime credit impaired (collectively assessed)

(10,155) - 10,155 -

Transfer to lifetime credit impaired (individually assessed)

- 400,000 100,000 500,000

Balance as at 31 March 2023

252,570 413,540 110,155 776,265

New loan advances

277,846 - - 277,846

Repayments

(195,637) (12,633) (9,582) (217,852)

Loan balances written off (collectively assessed)

- (907) - (907)

Loan balances written off (individually assessed)

- (362,852) - (362,852)

Transfer to lifetime not credit impaired

(19,451) 19,451 - -

Transfer to lifetime credit impaired (collectively assessed)

(1,434) - 1,434 -

Transfer to lifetime credit impaired (individually assessed)

- (37,148) 37,148 -

Balance as at 31 March 2024

313,894 19,451 139,155 472,500

*ECL - Expected Credit Losses

Ininstanceswheretheprobabilityof default hasincreasedsignificantly (a significant increasein creditrisk), or where theloan isin default, the

expectedcreditloss(orlossgivendefault)maynotincreasesignificantlyduetotheGroup’slendingcriteriawhichprohibitslendingwhentheloan

tovaluationratio(LVR)**exceeds75%.ThismeansingeneralthattheGroupexpectsthatthepresentvalueofexpectedcashflowsfromaloanin

defaulttoapproximatethecarryingvalueoftheloanpriortothedefaultevent,exceptincaseswheretheLVR**hasincreasedconsiderablydue

to a reduction in the security property valuation or a significant increase in the loan balance.

TheLVRofloanswithasignificantincreaseincreditriskorindefaultwasinarangeof50.5%-70.6%asat31March2024(March2023:inarange

of34.9%-67.2%),basedonthesecuritypropertyvaluationatorigination.ThelifetimeECLCreditImpairedloansaremadeupoftwoloans.$0.6m

was repaid or extended after the reporting date. Full recovery is expected from all loans.

36

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

NOTE 7: TERM DEPOSITS

20242023

$$

Gross term deposit liability

135,192,864 109,988,514

Less deferred commission expenditure

(74,317) (102,482)

Net carrying value

135,118,547 109,886,032

Contractual repayment terms:

On call

178,813 104,087

Within 12 months

88,839,334 77,329,770

Greater than 12 months

46,100,400 32,452,175

135,118,547 109,886,032

Repayment Terms:On call up to 5 years

Interest Rate:3.65% - 8.30% and 0.15% on call (March 2023: 3.65% - 7.75% and 0.15% on call)

Effective Interest Rate:3.65% - 8.30% and 0.15% on call (March 2023: 3.65% - 7.75% and 0.15% on call)

Security:

Further analysis of gross deposit funding is as follows:

Concentration of funding

20242023

$$

Northland

4,631,033 4,166,690

Auckland

53,614,586 47,277,149

Waikato

13,529,906 10,186,523

Bay of Plenty

11,861,471 10,314,064

Wellington

18,440,430 14,234,721

Other North Island

8,872,147 6,285,283

South Island

19,715,023 14,536,014

Overseas

4,528,268 2,988,070

Total gross term deposit liability

135,192,864 109,988,514

Contractual maturity of funding

20242023

$$

Maturing in 0 - 6 months40,974,805 45,295,457

Maturing in 6 - 12 months48,060,194 32,176,340

Maturing in 12 - 24 months35,221,462 21,984,844

Maturing after 24 months10,936,40310,531,873

Total gross term deposit liability

135,192,864 109,988,514

Profile of deposit holders

2024202420232023

$$

Deposits over $200,000

178

85,140,202

140

68,792,518

Deposits $100,000 - $200,000

170

23,478,598

117

16,323,173

Deposits $50,000 - $100,000

223

16,598,086

214

15,983,117

Deposits $20,000 - $50,000

236

7,948,537

213

7,034,278

Deposits $10,000 - $20,000

109

1,546,022

98

1,401,109

Deposits under $10,000

87

481,419

71

454,319

Total gross term deposit liability

1003

135,192,864

853

109,988,514

TheGrouphasatotalof1,003depositorsasat31March2024(March2023:853).Asatthereportingdate,thelargestdeposittheGrouphasis

$1,286,221 (March 2023: $1,224,361) which represents 0.95% (March 2023: 1.11%) of total deposits. As at the reporting date the largest

aggregateofdepositsunderasingledepositholdertotals$2,850,000(March2023:$3,000,000)whichrepresents2.11%(March2023:2.73%)of

totaldepositsandhaveaweightedaveragematuritydateof7.99monthsfromreportingdate(March2023:16.02monthsfromreportingdate).

$645,066 of the Term deposits held by related parties has been approved for early withdrawal on 28 April 2023 in compliance with General

Finance Limited ‘early repayment’ terms of offer criteria included in the General Finance Limited Product Disclosure Statement.

First rankingsecurityinterest over theassetsandundertakingsof GeneralFinanceLimitedinfavourof theTrustee

(subject only to any prior security interests permitted by the Trust Deed and preferential claims given priority by

operation of law).

37

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

NOTE 8: RISK MANAGEMENT

8.1 Credit risk

20242023

$$

Northland

6,146,498 1,412,729

Auckland

93,905,052 82,157,883

Waikato

3,268,816 3,671,767

Bay of Plenty

1,440,507 1,641,255

Wellington

6,172,735 8,403,589

Other North Island

8,082,401 6,000,304

Canterbury

10,931,866 3,622,661

Otago

2,017,465 3,144,922

Marlborough

2,175,565 451,064

Total

134,140,905 110,506,174

The Group is exposed to a variety of financial risks comprising credit risk, liquidity risk, market risk (interest rate risk) and fair value risk.

Creditriskistheriskof financiallosstotheGroupif acounterpartytoa financialinstrument failstomeetitscontractualobligations, andarises

principally from the Group's loan receivables, cash and cash equivalents, bank deposits and accounts receivable.

Asat31March2024theGroup’sloanadvancesaresecuredoverfirstmortgages100%(March2023:100%).Therewerenounsecuredloansasat

31 March 2024 (March 2023: none).

*LVR - Loan to Valuation Ratio

To manage credit on finance receivables the Group performs credit evaluations on all customers requiring advances. The approval process

considersanumberoffactorsincludingthevalueofthesecuritycomparedtothevalueoftheamounttobeborrowed("loantovaluationratio"or

"LVR"*), the creditworthiness of the borrower and their ability to repay.

TheGroupoperatesacreditrisk(lending)policywhichstipulatestheGroup'srequirementsregardingthesecurityandLVR*oftheborrowing,the

creditworthinessofborrowers,geographicalspread,maximumloanexposure sizeandcreditapprovalauthoritylevels.Decisionsonwhetherto

approve or decline loans are made by the credit committee in line with the Group's credit risk policy. Loan receivables are subject to regular

scrutiny,asakeycomponentofcreditriskmanagement. Thisincludesareviewoftheborrower’srepaymenthistoryandanyinterestarrears;any

changesintheborrowerscircumstanceswhichcouldimpactontheir ability to repay either interest or principal amounts on their due dateand

any movement in the security value.

The maximum credit exposure of the Group, assuming a zero value for collateral is $164,215,960 (2023: $134,570,790). This includes loans

receivableof$134,140,905(2023:$110,506,174),undrawnloancommitmentsof$2,052,306(2023:$7,510),bankdepositsof$28,017,664(2023:

$24,010,168), accounts receivable of $4,850 (2023: $46,213) and related party receivables of $235 (2023: $725). Of this exposure, 82.9% is

covered by collateral over properties (2023: 82.1%) and 17.1% is deposited with registered New Zealand banks (2023: 17.8%).

Loanreceivablescreditexposuresareconcentratedintheresidentialproperty sector, particularly inthe North Island andthe AucklandMarket.

Asat31March2024,advances bytheGroupintheNorth Islandresidentialpropertysector represented88.7% (March2023: 93.5%)of itstotal

exposure, with 70.0% (March 2023: 74.3%) being in the Auckland market. The geographical profile of loan receivables is analysed further as

follows:

38

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

20242023

Number of

Exposures

Number of

Exposures

Less than $100,000

- -

Between $100,000 and $250,000

14 8

Between $250,000 and $500,000

19 15

Between $500,000 and $1,000,000

45 38

Between $1,000,000 and $1,500,000

18 16

Between $1,500,000 and $2,000,000

20 10

Between $2,000,000 and $2,500,000

3 10

Between $2,500,000 and $3,000,000

4 3

Between $3000,000 and $3,500,000

- 1

Between $3,500,000 and $4,000,000

- 2

Between $4,000,000 and $4,500,000

1 -

Between $4,500,000 and $5,000,000

2 -

Between $5,000,000 and $5,500,000

- -

Between $5,500,000 and $6,000,000

1 -

Total No. of Exposures

127 103

As shown in the aging analysis of past-due loans below, the balance comprises:

Stage 1

Stage 2

Stage 3

Aging analysis – past due but not considered under-performing loans:

20242023

$$

Up to 30 Days

1,770,408 5,142,353

31 - 60 Days

7,275,651 5,415,857

61 - 90 Days

504,683 -

91 - 120 Days

- 555,465

120+ Days

802,704 3,506,381

Total

10,353,446 14,620,056

*ECL- Expected Credit Losses

12-month ECL*

Gross loans receivable totalling $1,770,408 (March 2023: $5,142,353) were pastdue andthe Grouphas concludedthere hasnot

been a significant increase in credit risk.

Lifetime ECL* not credit impaired

Grossloansreceivabletotalling$7,780,334(March2023:$5,415,857)werepastduebybetween30and90daysandtheGrouphas

concluded there has been a significant increase in credit risk.

Lifetime ECL* credit impaired

Gross loans receivable totalling $802,704 (March 2023: $4,061,846) were past due by greater than 90 days and the Group has

concluded there has been a significant increase in credit risk.

Theconcentrationofthecreditexposuretothesixlargestexposuresis18.8%(March2023:17.4%)ofthetotalloanportfolio.TheGrouphas

electedtodisclosethelargestsixexposuresasthisisconsideredtoprovideameaningfulindicationofconcentrationofcreditrisk.Anexposureis

calculated as the total of all loan exposures to a single borrower or group of linked borrowers.

The size of loan exposures is analysed further as follows:

The provision for expected credit losses for performing and under-performing loans is detailed and explained in note 6. Gross past due loan

receivables total $10,353,446 (March 2023: $14,620,056) which equates to 7.7% (March 2023: 13.2%) of total loan receivables.


TheGroupisalsoexposedtocreditriskfromdepositsheldwithbanks.Asatreportingdate,theGroupholdsdepositsinNewZealandRegistered

Banksincluding12.9%withBankofNewZealand(2023:40.3%),0.0%withASBBank(2023:1.3%),59.2%withHeartlandBank(2023:58.4%),5.6%

with Westpac New Zealand (2023: 0.0%), 22.3% with ANZ Bank New Zealand, of which 22.3% is held through Forsyth Barr custodial account (2023:

0.1%, no custodial account)

39

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

8.2 Liquidity risk

Liquidity risk is the risk that the Group will not be able to meet its obligations associated with financial liabilities as they fall due.

2024Total0 - 6 7 - 1213 - 24

24+

MonthsMonthsMonthsMonths

$$$$$

Financial assets

Amortised cost

Cash and cash equivalents

15,303,073 15,303,073 - - -

Bank deposits

13,165,370 5,998,667 7,166,703 - -

Other financial assets

19,985 19,985 - - -

Loan receivables

145,576,153 68,609,818 35,628,786 33,543,389 7,794,160

Totals

174,064,581 89,931,543 42,795,489 33,543,389 7,794,160

Financial liabilities

Amortised cost

Term deposits

145,372,958 43,902,980 50,943,680 38,076,355 12,449,943

Other payables

1,325,542 1,325,542 - - -

Totals

146,698,500 45,228,522 50,943,680 38,076,355 12,449,943

Net cashflow

27,366,081 44,703,021 (8,148,191) (4,532,966) (4,655,783)

2023Total0 - 6 7 - 1213 - 24

24+

MonthsMonthsMonthsMonths

$$$$$

Financial assets

Amortised cost

Cash and cash equivalents

14,085,363 14,085,363 - - -

Bank deposits

10,020,923 10,020,923 - - -

Other financial assets

68,591 68,591 - - -

Loan receivables

115,135,378 70,460,010 43,424,316 1,251,052 -

Totals

139,310,255 94,634,887 43,424,316 1,251,052 -

Financial liabilities

Amortised cost

Term deposits

116,607,943 47,036,067 34,013,191 23,855,967 11,702,718

Other payables

1,943,161 1,943,161 - - -

Totals

118,551,104 48,979,228 34,013,191 23,855,967 11,702,718

Net cashflow

20,759,151 45,655,659 9,411,125 (22,604,915) (11,702,718)

Contractual Cash Flows

The Group operates a liquidity risk policy and endeavours to maintain sufficient funds to meet its commitments based on forecasted cashflow

requirements. Management has internal control processes and contingency plans to actively manage the lending and borrowing portfolios to

ensurethenetexposuretoliquidityriskisminimised.Theexposureisreviewedonanon-goingbasisfromdailyprocedurestomonthlyreporting

as part of the Group's liquidity management policies and processes.

Contractual Cash Flows

Thefollowingtablessetouttheundiscountedcontractualcashflows,andtheundiscountedexpectedcashflows,of theGroup’s financialassets

and liabilities.

40

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

2024Total0 - 6 7 - 1213 - 24

24+

MonthsMonthsMonthsMonths

$$$$$

Financial assets

Amortised cost

Cash and cash equivalents

15,686,236 15,686,236 - - -

Bank deposits

13,165,370 5,998,667 7,166,703 - -

Other financial assets

19,985 19,985 - - -

Loan receivables

152,474,660 37,772,535 21,226,360 68,903,951 24,571,814

Totals

181,346,251 59,477,423 28,393,063 68,903,951 24,571,814

Financial liabilities

Amortised cost

Term deposits

154,835,296 19,692,023 22,797,682 45,216,718 67,128,873

Other payables

1,325,542 1,325,542 - - -

Totals

156,160,838 21,017,565 22,797,682 45,216,718 67,128,873

Net cashflow

25,185,413 38,459,858 5,595,381 23,687,233 (42,557,059)

2023Total0 - 6 7 - 1213 - 24

24+

MonthsMonthsMonthsMonths

$$$$$

Financial assets

Amortised cost

Cash and cash equivalents

14,361,602 14,361,602 - - -

Bank deposits

10,020,923 10,020,923 - - -

Other financial assets

68,591 68,591 - - -

Loan receivables

120,857,051 38,221,976 24,451,716 57,557,833 625,526

Totals

145,308,167 62,673,092 24,451,716 57,557,833 625,526

Financial liabilities

Amortised cost

Term deposits

123,586,143 20,987,638 15,510,520 39,981,225 47,106,760

Other payables

1,943,161 1,943,161 - - -

Totals

125,529,304 22,930,799 15,510,520 39,981,225 47,106,760

Net cashflow

19,778,863 39,742,293 8,941,196 17,576,608 (46,481,234)

-60% term deposit reinvestment rate for 31 March 2024 (March 2023: 60%).

-Cash and cash equivalents are expected to earn interest for the first six months at 5.01% pa

-Term deposit reinvestments are made for a weighted average 18-month term at 7.57% pa (March 2023: 18-month term at 6.94% pa).

-

The table above shows management’s expected maturities of existing financial assets and liabilities. In determining the expected cash flow, the

following assumptions have been made based on management’s best estimate having regard to past experience, current market conditions and

the future outlook including the ongoing post pandemic economic environment, high inflation, high interest rates, uncertainty in the property

market, financial market uncertainties and post natural disaster environment estimated impacts:

Expected Cash Flows

Expected Cash Flows

50% of loans (March 2023: 50%) not past due repay on existing contractual maturity date, with the balance rolled over at their existing

interest rates and repaid after a further 12 months.

41

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

8.3 Market risk

The table below summarises the sensitivity of the Group’s financial assets and liabilities to interest rate risk.

2024 Carrying Amount

-1% Profit before

tax

-1% Equity

+1% Profit

before tax

+1% Equity

Financial Assets

$ $ $ $ $

Cash and cash equivalents

15,303,073 (153,031) (110,182) 153,031 110,182

Loan Receivables

134,140,905 (1,341,409) (965,814) 1,341,409 965,814

Bank Deposits

12,714,591 (127,146) (91,545) 127,146 91,545

Financial Liabilities

Term Deposits

135,192,864 1,351,929 973,389 (1,351,929) (973,389)

Total increase / (decrease)

(269,657) (194,152) 269,657 194,152

2023 Carrying Amount

-1% Profit before

tax

-1% Equity

+1% Profit

before tax

+1% Equity

Financial Assets

$ $ $ $ $

Cash and cash equivalents

14,072,194 (140,722) (101,320) 140,722 101,320

Loan Receivables

110,506,174 (1,105,062) (795,645) 1,105,062 795,645

Bank Deposits

9,937,974 (99,380) (71,554) 99,380 71,554

Financial Liabilities

Term Deposits

109,988,514 1,099,885 791,917 (1,099,885) (791,917)

Total increase / (decrease)

(245,279) (176,602) 245,279 176,602

Interest rate risk is the risk of loss to the Group arising from adverse changes in interest rates. The Group's financing activities are exposed to

interestrateriskinrespectofitsinterestearningassetsandinterestbearingliabilities.ChangestointerestratescanimpacttheGroup'sfinancial

results by affecting the interest spread earned on these assets and liabilities. Interest rates for finance receivables, term deposits, and bank

deposits(otherthanthoseoncall)arefixedforthetermoftheirrespectivecontracts.Interestratesarerepricedoncontractualmaturitydatesof

thefinancialinstruments.Thereisariskthatdifferentfinancialinstruments(suchasloanreceivablesandtermdeposits)arerepricedondifferent

dates, i.e. a repricing risk (refer to contractual cash flows under liquidity risk for repricing dates).

Marketriskistheriskthatchangesinmarketprices,suchasinterestrateswillaffecttheGroup'sincomeorthevalueofitsholdingsoffinancial

instruments.

42

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

NOTE 9: SEGMENT REPORTING

$$$$$$

13,399,355 16,118 266,945 13,682,418 (3,276) 13,679,142

3,327,444 - - 3,327,444 - 3,327,444

- 135,695 - 135,695 2,361 138,056

- 409 - 409 - 409

3,190 4,000 681,468 688,658 (662,268) 26,390

- - - - - -

16,729,989 156,222 948,413 17,834,624 (663,183) 17,171,441

(8,096,442) - (3,276) (8,099,718) 3,276 (8,096,442)

(862,307) - - (862,307) - (862,307)

- (20,354) - (20,354) 2,929 (17,425)

7,771,240 135,868 945,137 8,852,245 (656,978) 8,195,267

(59,087) - - (59,087) - (59,087)

(1,530,721) (21,956) (238,883) (1,791,560) - (1,791,560)

(23,825) - (8,823) (32,648) - (32,648)

- - - - - -

(2,336,156) (54,373) (983,536) (3,374,065) 662,268 (2,711,797)

(938,360) - (12,600) (950,960) (1,481) (952,441)

2,883,091 59,539 (298,705) 2,643,925 3,809 2,647,734

156,967,691 955,791 5,940,759 163,864,241 (533,609) 163,330,631

136,525,549 3,796 482,404 137,011,749 (492,534) 136,519,214

Acquisition of property, plant and equipment, intangible assets, and other non-current assets (excluding non-current finance receivables):

$$$$$$

219,219 - 3,593 222,812 - 222,812

219,219 - 3,593 222,812 - 222,812

Year ended 31 Mar 2024

Dividend income

Eliminations

Total SegmentsFinance

Cost of sales

Personnel expenses

Impairment Expense -

intangible assets

Revenue - interest income

Revenue - fee income (loan

receivables)

Research and Advisory

Depreciation and

amortisation

Income Tax Expense

Management has determined the operating segments based on the components of the Group that engage in business activities, which have

discrete financial information available and whose operating results are regularly reviewed by the Group's chief operating decision maker. The

chief operating decision maker has been identified as the Board of Directors. The chief operating decision maker has been identified as the

executive directors.

Three reportable segments have been identified as follows:

- Finance: Deposit taking and short term property mortgage lending.

- Research and Advisory: Provides investment advisory services and produces and sells investment research and publications.

- Corporate and Other: Corporate function and investment activities.

Fee and commission

expense (finance

Net revenue

Increase in allowance for

expected credit losses

Year ended 31 Mar 2024

Corporate and

OtherFinance

Other

- Advisory fee revenue

- Yearbook and research

sales

Other expenses

Net profit / (loss) after tax

Total Assets

Consolidated

Total Segments

Interest expense

Consolidated

Eliminations

Corporate and

Other

Revenue from contracts

with customers

Total revenue

Other income

Total Liabilities

Research and Advisory

43

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

$$$$$$

10,580,049 6,573 37,757 10,624,379 (5,956) 10,618,423

2,980,148 - - 2,980,148 - 2,980,148

- 134,256 - 134,256 (69,266) 64,990

- 636 - 636 - 636

23,456 - 502,506 525,962 (480,906) 45,056

- - 2,474,234 2,474,234 (2,474,234) -

13,583,653 141,465 3,014,497 16,739,615 (3,030,362) 13,709,253

(5,224,192) - (5,563) (5,229,755) 5,956 (5,223,799)

(781,120) - - (781,120) - (781,120)

- (10,932) - (10,932) 6,926 (4,006)

7,578,341 130,533 3,008,934 10,717,808 (3,017,480) 7,700,328

(573,970) - - (573,970) - (573,970)

(1,032,028) - (186,334) (1,218,362) - (1,218,362)

(93,683) - (32,752) (126,435) - (126,435)

- (537,141) - (537,141) - (537,141)

(1,526,579) (67,019) (681,626) (2,275,224) 374,895 (1,900,329)

(1,106,760) - 1,293 (1,105,467) 19,619 (1,085,848)

3,245,321 (473,627) 2,109,515 4,881,209 (2,622,966) 2,258,243

129,256,532 854,324 6,097,813 136,208,669 (120,810) 136,087,859

111,697,481 19,105 203,208 111,919,794 (84,705) 111,835,089

Acquisition of property, plant and equipment, intangible assets, and other non-current assets (excluding non-current finance receivables):

$$$$$$

- - 10,476 10,476 - 10,476

- - 10,476 10,476 - 10,476

Year ended 31 Mar 2023Eliminations

Income tax (expense) /

benefit

Cost of sales

Depreciation and

amortisation

- Advisory fee revenue

Increase in allowance for

expected credit losses

Revenue - fee income (loan

receivables)

Total Assets

Revenue - interest income

Total Liabilities

Eliminations

Consolidated

Interest expense

Total revenue

Research and Advisory

Corporate and

Other

Year ended 31 Mar 2023

Dividend income

Impairment Expense -

intangible assets

Personnel expenses

Net profit / (loss) after tax

Finance

ConsolidatedResearch and Advisory

Other expenses

Net revenue

Corporate and

OtherFinanceTotal Segments

Other

Total Segments

Revenue from contracts

with customers

- Yearbook and research

sales

Other income

Fee and commission

expense (finance

44

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

NOTE 10: INTANGIBLE ASSETS

Bartercard

Trade

GoodwillLicencesDollars SoftwareTotal

$$$$$

Year ended 31 March 2023

Opening net book amount

2,350,730 277,000 290,348 638

2,918,716

Additions

- -

283

-

283

Disposals

- - (31,815) -

(31,815)

Amortisation charge

(537,141) - - (638)

(537,779)

Closing net book amount

1,813,589 277,000 258,816 - 2,349,405

At 31 March 2023

Cost

2,350,730 277,000 258,816 70,293 2,956,839

(537,141) - - (70,293) (607,434)

Net book amount

1,813,589 277,000 258,816 - 2,349,405

Bartercard

Trade Customer

GoodwillLicencesDollars RelationshipTotal

$$$$$

Year ended 31 March 2024

Opening net book amount

1,813,589 277,000 258,816 -

2,349,405

Additions

- - - 213,346

213,346

Disposals

- - (72,792) -

(72,792)

Amortisation and impairment charge

- - - (21,334)

(21,334)

Closing net book amount

1,813,589 277,000 186,024 192,012 2,468,625

At 31 March 2024

Cost

1,813,589 277,000 186,024 283,639 2,560,252

- - - (91,627) (91,627)

Net book amount

1,813,589 277,000 186,024 192,012 2,468,625

Impairment testing for cash-generating units (CGU)* containing brands and licences

20242023

Goodwill

$$

Allocated to the finance CGU*

1,323,729 1,323,729

Allocated to the research and advisory CGU*

489,860 489,860

1,813,589 1,813,589

Licences with an indefinite useful life

Allocated to the finance CGU*

247,000 247,000

Allocated to the research and advisory CGU*

30,000 30,000

277,000 277,000

Accumulated amortisation and impairment

Accumulated amortisation and impairment

*CGU - Cash Generating Unit

45

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

20242023

Impairment

$$

Impairment expense - Goodwill

- 537,141

Finance CGU*

Key assumptions used in value-in-use calculations

The key "base" assumptions used in the calculation of value-in-use for Finance CGU* are:

1) Loan receivables through the forecast period

2) Term Deposits through the forecast period

3) Loan weighted average interest rate growth through the forecast period

4) Term Deposit weighted average growth through the forecast period

5) Discount rates

6) Growth rates used to extrapolate cash flows beyond the forecast period

*CGU - Cash Generating Unit **FCFE - Free Cash flows to Equity Holders

The Group's indefinite useful life intangible assets have been tested for impairment at least annually. Research and Advisory & Finance CGU* was

last tested on 31 March 2024 with no impairment required. Impairment of $537,141 pertaining to the Research and Advisory CGU was recognised

in the year ended 31 March 2023.

The recoverable amount of the CGUs* has been determined based on value in use calculations. These calculations use pre-tax cash flow

projections based on financial budgets approved by management covering a five year period. Cash flows beyond the five year period are

extrapolatedusingtheestimatedlongtermgrowthratesstatedbelow.Thegrowthratedoesnotexceedthelongtermaveragefortheproducts,

industriesorcountryinwhichtheCGUs*operate.ForeachoftheCGU'swithgoodwillandindefinitelifelicences,thekeyassumptions,longterm

growth rate and discount rate used in the value in use calculations are as follows.

Theaggregatecarryingamountsofgoodwillandindefinitelifelicencesareoutlinedabove.Goodwillprimarilyrelatestogrowthexpectations,

expectedfutureprofitabilityandtheworkforceoftheCGU's*.TheGrouphasassessedthatthereisnoforeseeablelimittotheperiodoftimeover

which the goodwill and licences are expected to generate net cash inflows for the Group and as such they have been assessed as having an

indefinite useful life.

Pre-tax free cash flows to equity holders (FCFE)** have been forecasted based on growth in the non-bank deposit taking / residential lending

businesswithinthecurrentconstraintsofthelicence/trustdeedwhichprohibitstheCapitalRatiotogobelow8%.Theforecastedgrowthinnet

cash flows is driven primarily by the net interest and fee margin from forecasted growth in deposit funding and the loan book. Significant

expenditurehasbeenincurredsincethebusinesswaspurchasedbytheGrouptoensurethatthebusinesshasthecapacityandresourcestoallow

for the growth.

46

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

Total Loan Receivables

Total Term

Deposits

Loan weighted

average interest

rate

Term Deposit

weighted average

interest rate

Year one growth 31.2%31.1%0.9%1.9%

Year two growth13.2%14.8%0.0%0.0%

Year three growth11.7%12.9%0.0%0.0%

Year four growth10.5%11.4%0.0%0.0%

Year five growth9.5%10.3%0.0%0.0%

Terminal growth beyond year 5

2.0%

Pre-tax discount rate 19.7%

Total Loan Receivables

Total Term

Deposits

Loan weighted

average interest

rate

Term Deposit

weighted average

interest rate

Year one growth39.4%38.5%-1.3%32.8%

Year two growth19.3%18.2%-0.3%4.4%

Year three growth16.2%15.4%0.0%0.0%

Year four growth13.9%13.3%0.0%0.0%

Year five growth12.2%11.8%0.0%0.0%

Terminal growth beyond year 5

2.1%

Pre-tax discount rate 21.3%

Loan Receivable and Term Deposits

Lending and Term Deposit Interest rates

Terminal growth beyond year five

The table below sets out the key assumptions for the Finance CGU* for testing done as at 31 March 2024:

31 March 2023 Assumptions

Cashflowsbeyondthefiveyearperiodareextrapolatedusingtheestimatedlongtermgrowthrateof2.1%whichisWestpacforecastrate.Thisis

alsoconsistentwiththemidpointoftheReserveBankofNewZealandmediumtermConsumerPriceIndexPolicyTargetrange(1%to3%),witha

focusonkeepingfutureaverageinflationnearthe2%targetmidpoint.Thegrowthratedoesnotexceedthelongtermaveragefortheproducts,

industries or country in which the CGUs* operate.

31 March 2024 Assumptions

Themostrecenthistoricdataontermdepositwithdrawals,top-ups,andnewdepositswasreviewedtoestimatetrendsintermdepositinflows,

whichinturnfundedthegrowthinloanreceivables.Fortheyearended31March2024,theactualgrowthinloanreceivableswas22%,andterm

deposits grew by 23%.This islower thanlast year'sforecast, primarilydue to lower demandfor new loans throughout the year.Consequently,

management controlled the growth of term deposits to match the lending demand and the required cash and cash equivalent reserves.

Theforecastedgrowthof 31.2%inloanreceivablesand31.1% interm depositsfor theyear ending31March2025 isconservativecomparedto

theaverageannualgrowthof35.5%forloanreceivablesand33.3%fortermdepositsoverthemostrecentthreeyearsending31March2024.For

the remaining forecast periods, the most recent increase in total loan receivables and the corresponding increase in total term deposits, as a

percentage of the total loan receivable increase, were used as primary assumptions.

*CGU - Cash Generating Unit

Weighted average interest on loans was assumed based on the interest rates and maturities of the existing loans with an incremental monthly

review for new loans during the first forecast period to 31 March 2025. The weighted average lending rate as at 31 March 2025 was then carried

forward for the remainder of the forecast period as a proxy.

Group is anticipating an increase in weighted average rate on term deposits given the existing competitive nature of the industry and higher levels

of inflation rates. The rate is expected to plateau at the end of the first forecast period to 31 March 2025. The rate from 31 March 2025 was

carried forward for the remainder for the forecast period as a proxy.

47

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

Pre-tax discount rate

Sensitivity to change in key assumptions

Headroom/(Impairment)

$ '000

Base assumption65,514

Loan Receivable Growth57.0%

Term Deposit Growth-42.0%

Term Deposit interest rate Growth6.0%

Loan interest rate Growth-6.0%

Terminal growth beyond year 5

No material sensitivity

Pre-tax discount rate

No material sensitivity

Headroom/(Impairment)

$ '000

Base assumption65,514

Loan Receivable Growth + 10% above base51,812

Loan Receivable Growth - 10% below base74,066

Term Deposit Growth + 10% above base75,560

Term Deposit Growth - 10% below base50,322

Term Deposit interest rate Growth + 1% above base25,332

Term Deposit interest rate Growth - 1% below base45,908

Loan interest Growth + 1% above base46,220

Loan interest Growth - 1% below base25,020

The uncertainty in the cash flows for future periods has been built into discount rate.

The discount rates represent the current market assessment of the risks specific to the finance CGU*. The discount rate calculation is based on the

industry segment the CGU* is engaged in, and is derived from its weighted average cost of capital. The weighted average cost of capital takes into

account both the cost of debt and equity, however for the purposes of 31 March 2024 testing we put target Equity to Capital of 100%. The cost of

equity is derived from the expected return on investment by the Group’s investors using the capital asset pricing model allowing for unsystemic

risk adjustments. Segment-specific risk is incorporated by applying individual beta factors. The beta factors are evaluated based on publicly

available market data at the time of testing. Adjustments to the discount rate are made in order to reflect a pre-tax discount rate.

*CGU - Cash Generating Unit

The following summarises the impairment or headroom that would have resulted had the noted changes to the "base" assumptions been made,

with all other assumptions remaining constant:

The most sensitive assumptions in the calculation of value-in-use are term deposits growth, loan receivable growth, weighted average loan

interest rate growth and weighted average term deposit interest rate growth. The following summarises the amount by which the key

assumptions would need to change, with all other assumptions remaining constant, for the recoverable amount to equal the carrying amount:

The specific risk premium includes adjustments to the basic Capital Asset Pricing Model inputs to arrive at a risk adjusted cost of equity. These

adjustments include current market factors (other than systemic risks) and asset specific risks. In arriving at specific risk premium management

have considered factors such as:

1) Small Size Risk

2) Key Personnel Dependency Risk

3) Limited Product Line Risk

4) Geographical/Concentration Risk

5) Forecast Risk

48

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

Research and advisory CGU*

Key assumptions used in value-in-use calculations

31 March 2024 AssumptionsNet Revenue Expenditure

Working Capital

Movements

Pre-tax FCFF***

Actual 31 March 2024 year

119,750 (77,281) 4,359 46,828

Forecast 2025

124,417 (77,000) (1,048) 46,369

Forecast 2026

127,397 (78,844) (558) 47,995

Forecast 2027

234,559 (98,051) (586) 135,921

Forecast 2028

239,051 (99,929) (616) 138,506

Forecast 2029

243,605 (101,833) (646) 141,126

Terminal growth beyond year five

2.0%

Pre-tax discount rate22.1%

31 March 2023 AssumptionsNet Revenue Expenditure

Working Capital

Movements

Pre-tax FCFF***

Actual 31 March 2023 year

123,960 (67,019) (11,117) 45,824

Forecast 2024

151,590 (85,909) (1,815) 63,866

Forecast 2025

159,168 (92,705) (429) 66,034

Forecast 2026

164,340 (95,718) (451) 68,171

Forecast 2027

255,979 (118,192) (473) 137,314

Forecast 2028

262,378 (121,146) (407) 140,825

Terminal growth beyond year five

2.1%

Pre-tax discount rate21.5%

Net Revenue

Expenditure

The table below sets out the key assumptions for Research and Advisory CGU*:

*CGU - Cash Generating Unit

The key "base" assumptions used in the calculation of value-in-use for Research and Advisory CGU* are:

1) Net Revenue Expectations through the forecast period

2) Expenditure Expectations through the forecast period

3) Pre-tax Discount rates

4) Terminal Growth rates used to extrapolate cash flows beyond the forecast period

The Group is expecting expenditure to stay in line with historic trends, normalised for unusual/one off events. Most of these form part of the

Group recharges based on resources allocated. Salaries and Wages are driven by the project revenue and labour allocations required, these will

increase for the year ended 31 March 2027 and 31 March 2028, based on the normalised historic levels when Capital Raising/Listing Revenue has

been derived. Inflationary factor has been allocated to expenditures at 5% for the Forecast 2025; 3.25% for Forecast 2026; 2.75% for the Forecast

2027 and 2.5% for the Forecast 2028 and 2029.

Pre-tax free cash flows to the firm (FCFF)** has been forecasted based on expected revenue and expenditure growth in the research and advisory

business.

Net Revenue is calculated as gross revenue less forecast 15% direct commission.

Forecast Revenue consists of :

1)Debtstructuring/BrokerageRevenue:theGroupisanticipatingthatCapitalMarketswillneedmoreprofessionaladviceonthestructure,thisis

backed up by an increasing demand for the service. Group is expecting to perform 4 projects per annum in the forecast period based on the

number of projects performed for the year ended 31 March 2024.

2)CapitalRaising/ListingRevenue:NoCapitalRaisingrevenueisforecastforthe2yearsended31March2026duetotheunpredictablestateof

the economy & anticipated Group commitments. Capital Raising projects are forecast to start in the year ended 31 March 2027 and 31 March

2028aseconomyisassumedtostartpickingup.CapitalRaisingprojectsareassumedtorunona2yearbasisandprobabilityofsecuringprojects

is assumed at 70% per year. Value of the projects is set at historic average.

3) Other Income/Commissions Revenue - incidental ad hoc income based on historic trends.

It is assumed that all projects will be in the form of cash.

**FCFF - Free Cash flows to the Firm

49

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

Pre-tax discount rate

Terminal growth beyond year five

Sensitivity to changes in key assumptions

Headroom/(Impairment)

$

Net Revenue Growth + 10% above base

102,151

Net Revenue Growth - 10% below base

(102,151)

Expenditure Growth + 10% above base

(43,366)

Expenditure Growth - 10% below base

50,352

Pre-tax Discount rate Growth + 1% above base

(28,751)

Pre-tax Discount rate Growth - 1% below base

31,886

Terminal Growth rate Growth + 1% above base

16,478

Terminal Growth rate Growth - 1% below base

(14,918)

The discount rates represent the current market assessment of the risks specific to the Research and Advisory CGU*. The discount rate calculation

is based on the industry segment the CGU* is engaged in, and is derived from its weighted average cost of capital. The weighted average cost of

capital takes into account both the cost of debt and equity. The cost of equity is derived from the expected return on investment by the Group’s

investors using the capital asset pricing model allowing for unsystemic risk adjustments. The cost of debt is derived from weighted average

interest rate paid by the finance segment to deposit holders as at 31 March 2024. Segment-specific risk is incorporated by applying individual beta

factors. The beta factors are evaluated based on publicly available market data at the time of testing. Adjustments to the discount rate are made

in order to reflect a pre-tax discount rate.

Cashflowsbeyondthefiveyearperiodareextrapolatedusingtheestimatedlongtermgrowthrateof2.1%whichisWestpacforecastrate.Thisis

alsoconsistentwiththemidpointoftheReserveBankofNewZealandmediumtermConsumerPriceIndexPolicyTargetrange(1%to3%),witha

focusonkeepingfutureaverageinflationnearthe2%targetmidpoint.Thegrowthratedoesnotexceedthelongtermaveragefortheproducts,

industries or country in which the CGUs* operate.

The most sensitive assumptions in the calculation of value-in-use for the Research and Advisory CGU* is Revenue Growth; Expenses Growth;

Discountrateandlongtermgrowthrate.Thesensitivitytest oftheamountbywhichthekeyassumptionswouldneedtochange,withallother

assumptions remaining constant, for the recoverable amount to equal the carrying amount is not relevant, given that the base assumption is

break even position. The following summarises the impairment or headroom that would have resulted had the noted changes to the "base"

assumptions been made, with all other assumptions remaining constant:

The uncertainty in the cash flows for future periods has been built into the discount rate.

The specific risk premium includes adjustments to the basic Capital Asset Pricing Model inputs to arrive at a risk adjusted cost of equity. These

adjustments include current market factors (other than systemic risks) and asset specific risks. In arriving at specific risk premium management

have considered factors such as:

1) Small Size Risk

2) Key Personnel Dependency Risk

3) Limited product line Risk

4) Geographical/Concentration Risk

5) Forecast Risk

*CGU - Cash Generating Unit

50

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

NOTE 11: INVESTMENT IN SUBSIDIARIES

Subsidiary

20242023

Corporate Holdings Limited (CHL)Holding company

100.0%100.0%

General Finance LimitedFinance

100.0%100.0%

Investment Research Group LimitedResearch and advisory

100.0%100.0%

Commercial and General Finance LimitedDormant

100.0%100.0%

General Finance & Investments LimitedDormant

100.0%100.0%

General Finance & Leasing LimitedDormant

100.0%100.0%

General Leasing LimitedDormant

100.0%100.0%

General Loan and Finance LimitedDormant

100.0%100.0%

Mykco Limited (previously named General Capital Limited)Dormant

100.0%100.0%

All subsidiaries have a 31 March balance date.

NOTE 12: INVESTMENTS

20242023

$$

Investment in unlisted entities

126,624 214,730

NOTE 13: EQUITY

Number$Number$

(a) Ordinary shares

363,574,975 21,561,120 363,574,975 21,561,120

(b) Reserves

Financial Assets Share-basedTotal

at FVOCI*paymentsReserves

$$$

Balance at 1 April 2022

(280,314) 34,516 (245,798)

(73,713) - (73,713)

Balance at 31 March 2023

(354,027) 34,516 (319,511)

- (16,908) (16,908)

(31,240) - (31,240)

236,891 - 236,891

Balance at 31 March 2024

(148,376) 17,608 (130,768)

All ordinary shares rank equally and entitle the holder to participate in dividends and to share in the proceeds of winding up the Company in

proportion to the number of and amounts paid on the shares held. One vote is attached to each fully-paid ordinary share. Shares have no par

value.

2023

*FVOCI - Fair Value through Other Comprehensive Income

Revaluation of financial assets at FVOCI*

2024

Revaluation of financial assets at FVOCI*

Disposed financial assets transferred to retained earnings net of tax

Expired warrants converted to retained earnings

Ownership Interest Held

51

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

NOTE 14: EARNINGS PER SHARE

20242023

CentsCents

0.72 0.98

0.72 0.98

20242023

Basic earnings per share

$$

2,633,161

2,258,243

2,633,161

2,258,243

20242023

NumberNumber

363,574,975

230,023,343

363,574,975

230,023,343

NOTE 15: SHARE BASED PAYMENTS

Warrants issued to directors and senior managers

Number $

Balance at 1 April 2022

8,500,000 34,516

Balance at 31 March 2023

8,500,000 34,516

(4,250,000) (16,908)

Balance at 31 March 2024

4,250,000 17,608

NOTE 16: OTHER EXPENSES

Included in other expenses are the following amounts:

20242023

$$

Directors fees

463,642 420,790

Auditors Remuneration

- Audit and other assurance services

- Audit of financial statements (Grant Thornton New Zealand Audit Limited)

232,534 228,900

- Review of quarterly trustee certificates (Grant Thornton New Zealand Audit Limited)

3,000 3,000

Total remuneration paid to auditors

235,534 231,900

Directors' and Senior Managers'

Warrants

1

Warrants issued on 27 September 2021 lapsed on non satisfaction of

the terms of the warrant (note 13)

During the year ended 31 March 2024, 4,250,000 of warrants lapsed due to non-saftisfaction of the terms of the warrant. (31 March 2023: nil)

The Senior Management warrants comprise 4,250,000 2024 warrants which entitled the holder to subscribe for one ordinary share for each

warrant exercisable prior to 30 June 2024, at 9.0 cents per share.


The Senior Management warrants are not transferable and require the relevant senior manager to remain employed by or to be a contractor to

the Company at the date of the exercise. The warrants are not quoted on NZX.

Diluted earnings per share attributable to the ordinary equity holders

Weighted average number of ordinary shares used as the denominator in calculating basic

earnings per share

Basic earnings per share attributable to the ordinary equity holders

Profit / (loss) attributable to the ordinary equity holders of the Company used in

calculating basic earnings per share:

Profit / (loss) attributable to the ordinary equity holders of the Company used in

calculating diluted earnings per share:

Weighted average number of ordinary shares used as the denominator in calculating

diluted earnings per share

52

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

NOTE 17: TAXATION

17.1 Income tax

20242023

$$

Net operating profit before taxation

3,585,602 3,344,091

Income tax expense at prevailing rates (2024: 28%; 2023: 28%)

(1,003,969) (936,345)

Tax impact of expenses not deductible for tax purposes

(12,070) (159,619)

Tax impact of OCI deductible loss

78,446 -

Over-provision of tax in prior year

(14,848) 10,116

Taxation expense per the statement of comprehensive income

(952,441) (1,085,848)

Comprising:

- Current tax

(864,434) (1,264,253)

- Deferred tax

(88,007) 178,405

(952,441) (1,085,848)

17.2 Deferred tax asset

20242023

$$

Balance at beginning of year

313,454 135,049

(Charged) / credited to profit or loss

Increase / (decrease) in impairment loss provision

(85,054) 160,711

Increase / (decrease) in accrued expenses

(7,268) 13,767

Increase / (decrease) in lease liability

- (48,822)

Increase / (decrease) in unearned income

4,315 11,659

Increase / (decrease) in right of use asset

- 41,090

(88,007) 178,405

(Charged) / credited to other comprehensive income

Changes in the fair value of equity investments at fair value through other comprehensive income

(43,273) -

182,173 313,454

Deferred tax attributed to:

20242023

$$

Deferred tax assets:

Impairment loss provision

132,300 217,354

Accrued expenses

33,899 41,168

Fair value of equity investments at fair value through other comprehensive income

- 43,273

Unearned income

15,974 11,659

182,173 313,454

17.3 Imputation credit account

20242023

$$

Balance at beginning of year

966,368 204,395

Tax paid

1,460,165 770,418

Tax refund received

(15,149) (8,445)

2,411,384 966,368

53

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

NOTE 18: RECONCILIATION OF NET SURPLUS WITH CASH FLOWS FROM OPERATING ACTIVITIES

Note20242023

$$

Net profit after tax

2,633,161 2,258,243

Adjustment for non-cash and other items

Movement in allowance for expected credit losses

59,087 573,970

Impairment of Goodwill

10 - 537,141

Deferred tax movement

17 131,281 (178,405)

Depreciation and amortisation

9 32,647 126,435

Interest on lease liability

- 5,008

Adjustment for movements in working capital

(Increase) / decrease in loan receivables (net advances)

(23,144,389) (28,665,673)

Increase / (decrease) in term deposits (net receipts)

24,485,708 22,534,412

(Increase) / decrease in accrued interest on loans receivable

62,278 (369,482)

(Increase) / decrease in capitalised loan fees

(982,490) (880,116)

(Increase) / decrease in capitalised interest

23,908 398,461

(Increase) / decrease in accounts receivable

41,363 (28,863)

(Increase) / decrease in related party receivable

490 (725)

(Increase) / decrease in prepayments and other current assets

50,463 (126,730)

(Increase) / decrease in prepaid commission

28,164 (15,123)

(Increase) / decrease in Bartercard trade dollars

72,792 31,532

Increase / (decrease) in income tax payable

(654,274) 491,424

Increase / (decrease) in deferred income

621,151 207,523

Increase / (decrease) in interest payable

718,642 (679,435)

Increase / (decrease) in related party payable

(111,044) 104,219

Increase / (decrease) in accounts and other payables

111,018 230,569

Net cash (outflow) / inflow from operating activities

4,179,956 (3,445,615)

NOTE 19: RELATED PARTY BALANCES AND TRANSACTIONS

Related party receivables:

20242023

$$

Key Management Personnel

235 725

Related party payables:

20242023

$$

Key Management Personnel

6,366 117,410

The above amounts payable to related parties are unsecured, interest-free and repayable on demand.

Key Management Personnel (KMP) includes the Company’s Directors, subsidiary company Directors, Legal Counsel, and Chief Financial Officer.

54

GENERAL CAPITAL LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

Other related party balances:

20242023

$$

Term deposits held by related parties

1

1,300,724 2,342,793

Loans receivable from related parties

2

312,288 -

Transactions with related parties

20242023

Related PartyType Transaction

$$

Expense

1,181,431 986,963

Expense

101,682 224,778

Expense Recharge of expenses

284,130 356,582

Intangible Assets

Client Relationship

200,000 -

Contra Expense Recharge of expenses

20,238 30,310

NOTE 20: EVENTS SUBSEQUENT TO REPORTING DATE

-the operations, in financial years subsequent to reporting date, of the Group, or

-the results of those operations, or

-the state of affairs, in financial years subsequent to reporting date, of the Group.

Short term Remuneration

There has been no matters or circumstance, which has arisen since reporting date that has significantly affected or may significantly affect:

1

Key Management Personnel (KMP) includes the Company’s Directors, subsidiary company Directors, Corporate Counsel, and Chief Financial

Officer.

Key Management Personnel

(KMP)

1

Interest paid or capitalised on term deposits held by KMP or

their family members

1

Includes term deposits held by Key Management Personnel, Directors, their families and their controlled entities. During the year ended 31

March 2024 $645,066 of the Term deposits held by related parties has been approved for early withdrawal on 28 April 2023 in compliance with

the Company’s ‘early repayment’ terms of offer criteria included in the Company’s Product Disclosure Statement. ($3,677,705 approved for early

withdrwal during the year ended 31 March 2023).

2

On 24 January 2024, a capitalised interest loan of up to $359,092 was approved for a related party. The loan is an arms length transaction

conducted on normal commercial terms. (Year ended 31 March 2023: nil)

55

Ordinary shares
LARGEST HOLDERS OF QUOTED FINANCIAL PRODUCTS (as at 27 May 2024)

Ordinary Shares

Rank Registered Holder

Ordinary Shares

Held

%

1

Borneo Capital Limited

1

127,010,424

34.93%

2 API No 1 Limited Partnership

86,956,522

23.92%

3 Lynn Landmark Michel & Mat Floyd Trustee Co (No 1) Limited

34,782,609

9.57%

4 Brent Douglas King

22,115,317

6.08%

5 Snowdon Peak Investments Limited

14,882,720

4.09%

6 Owen Arvind Daji

7,030,463

1.93%

7 Olivia Ling

6,667,775

1.83%

8 Montezemolo Holdings Limited

6,511,945

1.79%

9 John Tomson

6,289,722

1.73%

10 Stephen John Sinclair & Jacqueline Margaret Sinclair & Roger Frederick Wallis 5,667,424 1.56%

11 Syed Hizam Alsagoff

4,000,000

1.10%

12Citibank Nominees (New Zealand) Ltd

3,297,873

0.91%

13

New Zealand Depository Nominee Limited

1

3,140,268

0.86%

14 Liyun Chen

2,000,000

0.55%

15 Garth William Ward

1,839,122

0.51%

16 Lik Sean Chang

1,494,305

0.41%

17 Sii Yih Ting

1,480,000

0.41%

18 CFS NBDT Interest Limited

1,387,280

0.38%

19 Saje Limited

1,333,333

0.37%

20 Koon Weng Lee

1,291,325

0.36%

339,178,427

93.29%

1

Borneo Capital Limited's share holding has been adjusted for 88,510 shares purchased through Sharesies. These shares are held by New Zealand

Depository Nominee Limited on behalf of Sharesies Nominee Limited, therefore these were adjusted for Borneo Capital Limited shares.

GENERAL CAPITAL LIMITED

SHAREHOLDER AND STATUTORY INFORMATION

Allordinarysharesrankequallywithonevoteattachedtoeachordinaryshare.Ordinarysharesentitletheholdertoparticipateindividendsand

the proceeds on the winding up of the Company in proportion to the number of shares held.

The Company had one class of quoted financial products on issue during the year ended 31 March 2024.

General Capital Limited (the Company) is a listed company on the NZX Main Board. Prior to 1 July 2019 the Company was listed on the New

Zealand Alternative Market (NZAX).

56

GENERAL CAPITAL LIMITED
SHAREHOLDER AND STATUTORY INFORMATION

SPREAD OF FINANCIAL PRODUCT HOLDERS (as at 27 May 2024)

Ordinary Shares

Size of Holding

Number of

Shareholders

%

Number of

Ordinary Shares

%

1 - 1,999

485

66.5%

31,972

0.0%

2,000 - 4,999

25

3.4%

71,282

0.0%

5,000 - 9,999

59

8.1%

440,403

0.1%

10,000 - 49,999

63

8.6%

1,443,444

0.4%

50,000 - 99,999

19

2.5%

1,289,546

0.4%

100,000 - 999,999

44

6.0%

9,627,060

2.6%

1,000,000 - 9,999,999

10

1.4%

7,106,297

2.1%

10,000,000 and over

24

3.3%

343,564,971

94.5%

729

100%

363,574,975

100%

Geographic Spread

New Zealand

620

85.0%

350,641,077

96.4%

Malaysia

66

9.1%

8,144,593

2.2%

Rest of World

43

5.9%

4,789,305

1.3%

729

100%

363,574,975

100%

SUBSTANTIAL PRODUCT HOLDERS (as at 31 March 2024)

The following information is provided pursuant to section 293 of the Financial Markets Conduct Act 2013.

Ordinary Shares

% of voting (ordinary)

shares at balance date

Borneo Capital Limited

127,010,424

34.93%

API No 1 Limited Partnership

86,956,522

23.92%

Brent Douglas King

1

36,998,037

10.18%

Lynn Landmark Michel & Mat Floyd Trustee Co (No 1) Limited

34,782,609

9.57%

285,747,592

Total Ordinary Shares on issue as at 31 March 2024

363,574,975

1

Includes holding by Brent Douglas King personally and as a sole director and shareholder of Snowdon Peak Investments Limited.

As at 31 March 2024 the Company had the following shareholders that are registered by the company as Substantial Product Holders in the

Company, having disclosed a relevant interest in quoted voting products under the Financial Markets Conduct Act 2013.

57

GENERAL CAPITAL LIMITED
SHAREHOLDER AND STATUTORY INFORMATION

DIRECTORS' REMUNERATION AND OTHER BENEFITS FOR THE PERIOD ENDED 31 MARCH 2024

Directors Fees

2

Other Remuneration

$$

Rewi Hamid Bugo

1

56,000 60,000

Brent Douglas King

3

35,000 386,410

Huei Min Lim (ceased 31 May 2023)

5,333 -

Gregory Stephen James

32,000 -

Paul William Zingel

32,000 -

Megan Dominique Glen

32,000 -

Simon John McArley (ceased 17 July 2023)

14,933 -

Donald Frederick Hattaway (director of subsidiary)

54,200 -

Robert Garry Hart (director of subsidiary) (ceased 31 October 2023)

20,417 -

Anton Steven Ian Douglas (director of subsidiary, ceased 8 Nov 2023)

17,500 -

Gregory John Pearce (director of subsidiary)

5

41,400 109,158

Anita Maria Killeen

5,333 -

346,116 555,568

$

Base salary

310,000

FY24 Bonus

25,000

Other benefits

4

51,410

386,410

Other Remuneration of the Managing Director:

The employment contract between the Company and Brent Douglas King is deemed to be a Material Transaction as defined by the NZX Listing

Rules (the Rules) and is subject to the exception under 5.2.2(e) of the Rules.

5

Other remuneration paid to Gregory John Pearce comprises of commission for credit control/recovery and loan administration.

2

The above fees are recorded exclusive of GST, if any.

4

OtherbenefitscompriseofKiwisaver,vehicleallowance,anda10%commissiononallconsultingrevenuechargedbyInvestmentResearch

Group Ltd.

3

Other remuneration paid to Brent Douglas King comprises salaries and other benefits paid to Brent Douglas King in his capacity as Managing

Director of General Capital Limited and its subsidiaries. Brent Douglas King's other remuneration is broken down below.

1

Other remuneration paid to Rewi Hamid Bugo comprises of travel allowance.

58

GENERAL CAPITAL LIMITED
SHAREHOLDER AND STATUTORY INFORMATION

DIRECTORS INTEREST REGISTER

DIRECTORS DEALINGS IN QUOTED FINANCIAL PRODUCTS DURING THE YEAR ENDED 31 MARCH 2024

Date of

Transaction

Financial

Product

Number of

Financial

Products

Acquired /

(disposed)

Consideration

(received) / paid $

Rewi Hamid Bugo

1

14 & 15 June 2023

Ordinary Shares

237,181

19,561

Rewi Hamid Bugo

1

7, 13, 20 July 2023

Ordinary Shares

(237,181)

(16,802)

Gregory Stephen James

02 & 12 June 2023

Ordinary Shares

100,242

7,200

Relevant Interests

DIRECTORS QUOTED FINANCIAL PRODUCT HOLDINGS AT 31 MARCH 2024

Ordinary Shares

Management

Warrants

NumberNumber

Rewi Hamid Bugo

1

127,010,424 -

Paul William Zingel

2

34,782,609 -

Brent Douglas King

6

22,115,317 4,250,000

Brent Douglas King

3

14,882,720 -

Gregory Stephen James

440,925 -

86,956,522 -

Donald Frederick Hattaway (director of subsidiary)

5

892,890 -

Gregory John Pearce (director of subsidiary)

50,000 -

287,131,407 4,250,000

Relevant Interests

Other Notes

1

DeemedrelevantinterestbyvirtueofRewiHamidBugoowningmorethan20%ofthevotingproductsofBorneoCapitalLimited(theregistered

holder). Shares were acquired during June 2023 and disposed of in July 2023.

Megan Dominique Glen

4

1

DeemedrelevantinterestbyvirtueofRewiHamidBugoowningmorethan20%ofthevotingproductsofBorneoCapitalLimited(theregistered

holder).

2

Deemed relevant interest by virtue of Paul William Zingel being an associate of the trustees of Bedford Trust (the registered holders).

6

On 27 September 2021, Brent Douglas King in his capacity as a senior manager of General Capital Limited was issued4,250,000 warrantsthat

entitletheholderofeachwarranttosubscribeforcashforoneordinaryshareintheCompanyatanexercisepriceof9.0centspershareatany

time prior to 30 June 2024.

5

Deemed relevant interest by virtue of Donald Frederick Hattaway being a director of Casrom Trustee Company Limited a trustee of Romana

Benevolent Trust (the registered holders).

3

Deemedrelevant interestbyvirtueof BrentDouglasKingowningmorethan20%ofthevotingproductsof SnowdenPeakInvestmentsLimited

(the registered holder).

4

Deemed relevant interest by virtue of Megan Dominique Glen owning more than 20% of the voting products of Minatoku Consulting Limited

holding 0.5% interest in the total partnership interest on issue of API No 1 Limited Partnership (the registered holder).

59

GENERAL CAPITAL LIMITED
SHAREHOLDER AND STATUTORY INFORMATION

DIRECTORS INTEREST REGISTER (CONTINUED)

During the year ended 31 March 2024, pursuant to section 140 of the Companies Act 1993 the directors disclosed the following interests:

Brent Douglas King

Equity Investment Advisers Limited

Moneyonline Limited

Snowdon Peak Investments Limited

Paul William Zingel

Bedford Trust

Rewi Hamid Bugo

Borneo Capital Limited

Megan Dominique Glen

API No1 Limited PartnershipMinatoku Consulting Limited

Donald Frederick Hattaway (director of subsidiary)

Casrom Trustee Company LimitedRomana Benevolent Trust

Anton Steven Ian Douglas (director of subsidiary) (ceased 8 November 2023)

API No 1 Limited PartnershipGrey River Capital Advisors Limited

Robert Garry Hart (director of subsidiary) (ceased 31 October 2023)

Ellice Tanner Hart Limited

INDEMNITY AND INSURANCE

EMPLOYEE REMUNERATION

Remuneration Range20242023

$100,000 - $109,9991-

$110,000 - $119,999--

$120,000 - $129,9991-

$130,000 - $139,99912

$140,000 - $149,999--

$150,000 - $159,0001-

$160,000 - $169,999--

$170,000 - $179,999--

$180,000 - $189,999--

$190,000 - $199,999--

$200,000 - $209,999-1

$210,000 - $219,999--

$220,000 - $229,999--

$230,000 - $239,999--

$240,000 - $249,999 2-

DONATIONS MADE

During the year ended 31 March 2024 the Group made total donations of $6,417.

Duringtheyearended31March2024,thenumberofemployeesorformeremployeesoftheGroupnotbeingdirectorsofGeneralCapitalLimited

orsubsidiaries,whoreceivedremunerationandotherbenefitsintheircapacityasemployees,thevalueofwhichexceeded$100,000fortheyear

was as follows:

Number of Employees

In accordance with section 162 of the Companies Act 1993, the Group has provided insurance for and indemnities to, directors and employees of

the Group for losses from actions undertaken in the course of their duties. The insurance includes indemnity costs and expenses incurred to

defend an action that falls outside the scope of the indemnity.

60

REGISTERED OFFICE:General Capital Limited
Level 8, General Capital House

115 Queen Street

Auckland 1010

New Zealand

PO Box 1314

Shortland Street

Auckland 1010

New Zealand

Email:info@gencap.co.nz

Web:www.gencap.co.nz

Phone:(09) 526 5000

AUDITOR:Grant Thornton New Zealand Audit Limited

Level 4, Grant Thornton House

152 Fanshawe Street

Auckland CBD

Auckland 1010

SHARE REGISTER:Computershare Investor Services Limited

Level 2, 159 Hurstmere Road

Takapuna

Auckland 0622

BANKERS:Bank of New Zealand

ANZ Bank New Zealand Limited

ASB Bank Limited

Westpac New Zealand Limited

Heartland Bank Limited

GENERAL CAPITAL LIMITED

CORPORATE DIRECTORY

61

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.